<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge">
    <meta content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=no" name="viewport">
    <meta name="description" content="نظام معلومات الأدوية السعودي Saudi Drugs Information System">
    <meta name="author" content="Saudi Food & Drug Authority (SFDA)">
    <noscript><meta http-equiv="refresh" content="0; url=/noScript.html" /></noscript>
    <link rel="shortcut icon" href="/favicon.ico">
    <title>&#x646;&#x638;&#x627;&#x645; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</title>
    <link href="/fonts/roboto/roboto.css?v=53F8z0aw8DRnG9ou9x1tuKMPbNjRZWM-VBHl3B0s9-o" rel="stylesheet" />
    <link href="/fonts/material-icons/materialicons.css?v=8pEJ8MWsFzHRDLY0NI5rssf6T6vankxrJDPnnZxOGrg" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-rtl.css?v=0env-Atj9mTPLILmJGwuDlLIOS_Akxxy4gnH1UUtrjU" rel="stylesheet" />
    <link href="/lib/bootstrap/dist/css/bootstrap-glyphicons.css?v=U5a39oen_WYzVAAexH5aoahbpqlKHcIzQrnXujf1yio" rel="stylesheet" />
    <link href="/lib/bootstrap-select/dist/css/bootstrap-select.css?v=DeY2lH0e0tmNnO9XZ-gGVOGk6_YoWlZ49y7CnD3ST00" rel="stylesheet" />
    <link href="/lib/toastr/toastr.css?v=kKePN_CyxTiMEgsSDu_7z21ru07YOZtR-0UV0JOkt5o" rel="stylesheet" />
    <link href="/lib/famfamfam-flags/dist/sprite/famfamfam-flags.css?v=JVJiF3s2_kk99xQHfYhfxo_-Dd52ZIruDMOILwPkqv0" rel="stylesheet" />
    <link href="/lib/font-awesome/css/font-awesome.css?v=YIHlqxkiJtENTMuzIHC9EfZaB5RniGr7kF7juUQJUuc" rel="stylesheet" />
    <link href="/lib/Waves/dist/waves.css?v=nd3hxjNg6DhkuFIz5IbxLK8Xw2ac0blsDQpF4pkJxUc" rel="stylesheet" />
    <link href="/lib/animate.css/animate.css?v=IT6GQizZpVcaM1_L_mIiNAYVvZErMgfwewf1GGWXG_I" rel="stylesheet" />
    <link href="/css/materialize.css?v=ey-J3xahkqficOYUHVX3jexmzvRFrge9bmux4CQr1DQ" rel="stylesheet" />
    <link href="/css/Publicstyle.css?v=xhOiVjq-54ODzSIeHXoascHsEJm_n_bIHqZatpxnYhg" rel="stylesheet">
    <link href="/css/Comman.css?v=bcS6_IRqBsBcY1mS_iriWWanrYR0Scdo1ffk8rQGXwQ" rel="stylesheet" />
    <link href="/css/themes/all-themes.css?v=eGSl5zNTWrXYfUx_EJW9ksC3CUTUUxvxmPiA3aQDtQo" rel="stylesheet" />
    <link href="/view-resources/Views/Shared/_Layout.css?v=BLxBuNISlF2O5EBHWdsX039NvnIHy-GtcqeI_MbyIc0" rel="stylesheet" />
    <link href="/lib/enjoyhint/enjoyhint.css?v=rSxIyBbiAvx_48ZcFxbn2DNPCCgEc0FXa2Vb72enxk4" rel="stylesheet" />
    <link href="/lib/dropzone/dropzone.css?v=IQDlHJdeYZ4gMH87EuB1yEG7ujA7DSEkV_SWfACk8Rg" rel="stylesheet" />

    <!-- View specific styles -->
    
    <script type="text/javascript" nonce="c7f26c8w">
        // This is used to get the application's root path from javascript. It's useful if you're running application in a virtual directory under IIS.
        var abp = abp || {};
        abp.appPath = '/';

    </script>
    <style>
        .popover .popover-title {
            text-align: right;
            font-weight: bold;
        }
        .popover .popover-content {
            text-align: right;
            font-size: 14px;
            font-family: 'Almarai', sans-serif;
            color: black;
        }
       
    </style>
</head>
<body>
    <!-- Page Loader -->
    <div class="page-loader-wrapper">
        <div class="loader">
            <div class="preloader">
                <div class="spinner-layer pl-blue">
                    <div class="circle-clipper left">
                        <div class="circle"></div>
                    </div>
                    <div class="circle-clipper right">
                        <div class="circle"></div>
                    </div>
                </div>
            </div>
            <p>&#x628;&#x631;&#x62C;&#x627;&#x621; &#x627;&#x644;&#x625;&#x646;&#x62A;&#x638;&#x627;&#x631; ...</p>
        </div>
    </div>
    <!-- #END# Page Loader -->
    <!-- Overlay For Sidebars -->
    <div class="overlay"></div>
    <!-- #END# Overlay For Sidebars -->
    <!-- Search Bar -->
    <!-- Top Bar -->
    <nav class="navbar navbar-inverse naav" style="margin-bottom: 0;">
        <div class="container-fluid">
            <div class="navbar-header">
                <button type="button" class="navbar-toggle" data-toggle="collapse" data-target="#myNavbar">
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                    <span class="icon-bar"></span>
                </button>
            </div>
            <div class="collapse navbar-collapse rtl" id="navbar-collapse">
                <ul class="nav navbar-nav navbar-right">
                    <li><a href="/home/DrugSearch">&#x627;&#x644;&#x623;&#x62F;&#x648;&#x64A;&#x629;</a></li>
                        <li><a href="/Account/Login"><i class="fa fa-key"></i>&nbsp;&#x62A;&#x633;&#x62C;&#x64A;&#x644; &#x627;&#x644;&#x62F;&#x62E;&#x648;&#x644;</a></li>
                </ul>
                <ul class="nav navbar-nav navbar-left">
                    <li class="dropdown">
    <a href="javascript:void(0);" class="dropdown-toggle" data-toggle="dropdown" role="button">
        <i class="famfamfam-flags sa" title="&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;"></i>
        <span>&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</span>
        <b class="caret"></b>
    </a>
    <ul class="dropdown-menu pull-right">
                <li><a href="/AbpLocalization/ChangeCulture?cultureName=en"><i class="famfamfam-flags gb"></i> English</a></li>

    </ul>
</li>

                </ul>
            </div>
        </div>
    </nav>
    <section id="mainContent" class="content">
        <nav class="navbar naav" style="margin-bottom: 0;">
            <div class="container-fluid">
                <ul class="nav navbar-nav">
                    <li>
                        <a class="text-center" href="/">
                            <img src="/images/logo_sdi.png" style="margin: auto;" width="250">
                        </a>
                    </li>
                </ul>
                <div class="navbar-header navbar-toggle2 ">
                    <button type="button" class="navbar-toggle navbar-toggle2" data-toggle="collapse"
                            data-target="#myNavbar2">
                        <span class="icon-bar icon-bar2 "></span>
                        <span class="icon-bar icon-bar2"></span>
                        <span class="icon-bar icon-bar2"></span>
                    </button>
                </div>
                <div class="collapse navbar-collapse " id="myNavbar2">
                    <ul class="nav navbar-nav">
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover" data-placement="bottom" title="" data-content="موقع الكترونى يمكن شركات ووكلاء الادويه من رفع النشرات الممارس الصحى ونشرة معلومات المريض وصورة عبوة الدواء المعتمدة من الهيئة العامة للعذاء والدواء بهدف بناء مرجع وطنى للادوية المسجلة يمكن الرجوع له من قبل الممارس الصحى والمريض كمصدر موثوق للمعلومات الدوائية"
                               data-original-title="&#x645;&#x646; &#x646;&#x62D;&#x646;">
                                &#x645;&#x646; &#x646;&#x62D;&#x646;
                            </a>
                        </li>
                        <li>
                            <a href="#" class="text-right waves-effect" data-trigger="focus"
                               style="color: #4276a1;" data-container="body" data-toggle="popover"
                               data-placement="bottom"
                               title=""
                               data-content="&#x627;&#x630;&#x627; &#x643;&#x627;&#x646; &#x644;&#x62F;&#x64A;&#x643;&#x645; &#x645;&#x644;&#x627;&#x62D;&#x638;&#x627;&#x62A; &#x627;&#x648; &#x627;&#x642;&#x62A;&#x631;&#x627;&#x62D;&#x627;&#x62A; &#x64A;&#x631;&#x62C;&#x649; &#x627;&#x644;&#x62A;&#x648;&#x627;&#x635;&#x644; &#x639;&#x644;&#x649;   SDI@SFDA.GOV.SA"
                               data-original-title="&#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;">
                                &#x62A;&#x648;&#x627;&#x635;&#x644; &#x645;&#x639;&#x646;&#x627;
                            </a>
                        </li>

                    </ul>
                </div>
            </div>
        </nav>
        

<div class="col-xs-12">
    <div class="row text-center">
        <a href="/" class="btn bg-blue btn-lg m-b-10 hover-white">&#x628;&#x62D;&#x62B; &#x62C;&#x62F;&#x64A;&#x62F;</a>
    </div>
</div>
<div class="jumbotron" style="margin-bottom: 0px; background-color: white !important;">
    <h3 class="text-center" style="color: #57aabf; ">Search Results</h3>
    <hr width="20%" style="border-top: 3px solid #54ae90;">

    <br>
    <table class="table s-row">
        <thead style="margin-bottom: 30px !important">
                <tr>
                    <th id="M" style="color:white;">
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x627;&#x644;&#x645;&#x645;&#x627;&#x631;&#x633; &#x627;&#x644;&#x635;&#x62D;&#x64A;</a>
                    </th>
                    <th id="A" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x639;&#x631;&#x628;&#x64A;&#x629;</a>
                    </th>
                    <th id="E" style="color:white;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x646;&#x634;&#x631;&#x629; &#x645;&#x639;&#x644;&#x648;&#x645;&#x627;&#x62A; &#x627;&#x644;&#x645;&#x631;&#x64A;&#x636; &#x628;&#x627;&#x644;&#x627;&#x646;&#x62C;&#x644;&#x64A;&#x632;&#x64A;&#x629;</a>
                    </th>
                    <th id="f" class="active-tab" type='button'>
                        <a href="javascript:void(0)" style="color: white;">&#x635;&#x648;&#x631; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>
                    <th id="D" style="color:white; background-color: #47a4ba;" type='button'>
                        <a href="javascript:void(0)"
                           style="color: white;">&#x628;&#x64A;&#x627;&#x646;&#x627;&#x62A; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</a>
                    </th>

                </tr>
        </thead>
    </table>
    <div id="D-div" class="box-data" style="display: block;">
        <div class="row">

<div class="modal-body rtl">
    <div class="tab-content">
        <div role="tabpanel" class="tab-pane m-r-60  animated fadeIn active" id="edit-user-details">
<div class="row clearfix">
                    <div class="col-lg-6 col-md-6 col-sm-6">
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="RegisterNumber">&#x631;&#x642;&#x645; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        1811246234
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="RegisterYear">&#x633;&#x646;&#x629; &#x627;&#x644;&#x62A;&#x633;&#x62C;&#x64A;&#x644;</label>
                                    <div class="form-line">
                                        2019
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="TradeName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x62A;&#x62C;&#x627;&#x631;&#x64A;</label>
                                    <div class="form-line">
                                        NEO-MERCAZOLE 5MG TAB
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label col-view" for="ScientificName">&#x627;&#x644;&#x627;&#x633;&#x645; &#x627;&#x644;&#x639;&#x644;&#x645;&#x64A;</label>
                                    <div class="form-line">
                                        CARBIMAZOLE
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label " for="Strength">&#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        5
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="StrengthUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62A;&#x631;&#x643;&#x64A;&#x632;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="AdministrationRouteName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x625;&#x633;&#x62A;&#x639;&#x645;&#x627;&#x644;</label>
                                    <div class="form-line">
                                        Oral use
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PharmaceuticalFormName">&#x627;&#x644;&#x634;&#x643;&#x644; &#x627;&#x644;&#x635;&#x64A;&#x62F;&#x644;&#x627;&#x646;&#x64A;</label>
                                    <div class="form-line">
                                        Tablet
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Size">&#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="SizeUnitName">&#x648;&#x62D;&#x62F;&#x629; &#x627;&#x644;&#x62D;&#x62C;&#x645;</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageSize">&#x62D;&#x62C;&#x645; &#x627;&#x644;&#x639;&#x628;&#x648;&#x629;</label>
                                    <div class="form-line">
                                        100
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="PackageTypeName">&#x627;&#x646;&#x648;&#x627;&#x639; &#x627;&#x644;&#x639;&#x628;&#x648;&#x627;&#x62A;</label>
                                    <div class="form-line">
                                        Bottle
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="LegalStatusName">&#x637;&#x631;&#x64A;&#x642;&#x629; &#x627;&#x644;&#x635;&#x631;&#x641;</label>
                                    <div class="form-line">
                                        Prescription
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6">
                                <div class="form-group">
                                    <label class="form-label" for="ProductControlName">&#x62D;&#x627;&#x644;&#x629; &#x627;&#x644;&#x645;&#x631;&#x627;&#x642;&#x628;&#x629;</label>
                                    <div class="form-line">
                                        Uncontrolled
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="DrugTypeName">&#x646;&#x648;&#x639; &#x627;&#x644;&#x62F;&#x648;&#x627;&#x621;</label>
                                    <div class="form-line">
                                        Generic
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="ShelfLife">&#x645;&#x62F;&#x629; &#x627;&#x644;&#x635;&#x644;&#x627;&#x62D;&#x64A;&#x629; &#x628;&#x627;&#x644;&#x623;&#x634;&#x647;&#x631;</label>
                                    <div class="form-line">
                                        36
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="StorageConditionsName">&#x634;&#x631;&#x648;&#x637; &#x627;&#x644;&#x62A;&#x62E;&#x632;&#x64A;&#x646;</label>
                                    <div class="form-line">
                                        store below 25°c
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="Price">&#x633;&#x639;&#x631; &#x627;&#x644;&#x62C;&#x645;&#x647;&#x648;&#x631; &#x628;&#x627;&#x644;&#x631;&#x64A;&#x627;&#x644;  ( &#x627;&#x644;&#x633;&#x639;&#x631; )</label>
                                    <div class="form-line">
                                        21.85
                                    </div>
                                </div>
                            </div>
                        </div>
                        <div class="row clearfix">
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Manufacture_NameEn" name="Manufacture.NameEn" value="Amdipharm Limited" />
                                        <label class="form-label" for="Manufacture_NameEn">&#x627;&#x644;&#x645;&#x635;&#x646;&#x639;</label>
                                        <div class="form-line">
                                            Amdipharm Limited
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <input type="hidden" id="Agent" name="Agent" value="[Agent 354]" />
                                        <label class="form-label">&#x627;&#x644;&#x648;&#x643;&#x64A;&#x644;</label>
                                        <div class="form-line">
                                            SAUDI INTERNATIONAL TRADING COMPANY LTD (SITCO)
                                        </div>
                                    </div>
                                </div>
                                <div class="col-sm-6 col-lg-6">
                                    <div class="form-group">
                                        <label class="form-label" for="Company_NameEn">&#x627;&#x644;&#x634;&#x631;&#x643;&#x629; &#x627;&#x644;&#x645;&#x633;&#x648;&#x642;&#x629;</label>
                                        <div class="form-line">
                                            AMDIPHARMA
                                        </div>
                                    </div>
                                </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode1">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 1</label>
                                    <div class="form-line">
                                        H03BB01
                                    </div>
                                </div>
                            </div>
                            <div class="col-sm-6 col-lg-6">
                                <div class="form-group">
                                    <label class="form-label" for="AtcCode2">&#x643;&#x648;&#x62F; &#x627;&#x644;&#x643;&#x64A;&#x645;&#x64A;&#x627;&#x621; &#x627;&#x644;&#x639;&#x644;&#x627;&#x62C;&#x64A;&#x629; &#x627;&#x644;&#x62A;&#x634;&#x631;&#x64A;&#x62D;&#x64A;&#x629; 2</label>
                                    <div class="form-line">
                                        
                                    </div>
                                </div>
                            </div>
                        </div>
                    </div>
                </div>
        </div>
    </div>
</div>

        </div>
    </div>
    <div id="E-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> SFDA PIL</span>
                <span style="font-size:small;">  (Patient Information Leaflet (PIL) are under review by Saudi Food and Drug Authority)</span>

            </div>
</div>


<div class="clearfix ltr">
    <div class="col-lg-12 col-md-12 col-sm-12 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="InventedNameEn">1. What this product is and what it is used for</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Pharmacotherapeutic group: </strong>NeoMercazole&reg; contains the active substance carbimazole. NeoMercazole&reg; belongs to a group of medicines called anti-thyroid agents.</p><p><strong>Therapeutic indications:</strong></p><p>NeoMercazole&reg;&nbsp;is used to reduce the formation of thyroid hormones in people with an overactive thyroid gland. The condition is called hyperthyroidism.</p><p>NeoMercazole&reg; is also used in more serious cases, for example, to restore the normal function of the thyroid before its partial removal by surgery. It may also be used together with other treatments for hyperthyroidism</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="form-group clearfix">
            <label style="float: left" class="h2" for="PrecautionsEn">2. What you need to know before you use this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>3.&nbsp; </strong><strong>BEFORE YOU TAKE NEOMERCAZOLE</strong><strong>&reg;</strong></p><p><strong>a. Do not take NeoMercazole</strong><strong>&reg;</strong></p><p>-&nbsp;&nbsp; If you are allergic (hypersensitive) to carbimazole or any of the ingredients of NeoMercazole&reg;.</p><p>-&nbsp;&nbsp; If you are allergic (hypersensitive) to other anti-thyroid medicines such as thiamazole, methimazole or propylthiouracil.</p><p>-&nbsp;&nbsp; If you are breast-feeding.</p><p>-&nbsp;&nbsp; If you have a serious blood disorder.</p><p>-&nbsp;&nbsp; If you have a severe liver disorder.</p><p>-&nbsp;&nbsp; If you had inflammation of the pancreas (acute pancreatitis) after administration of carbimazole or thiamazole in the past.</p><p><strong>b. Take special care with NeoMercazole</strong><strong>&reg;</strong></p><p>-&nbsp;&nbsp; If you have a swelling in your neck called an &#39;intrathoracic goitre&#39;.</p><p>-&nbsp;&nbsp; If you have bone marrow depression.</p><p>-&nbsp;&nbsp; If you are receiving radio-iodine (for thyroid problems).</p><p>-&nbsp;&nbsp; If you are of child-bearing potential.</p><p>-&nbsp;&nbsp; If you are allergic to thiamazole, methimazole or propylthiouracil (other thyroid medications).</p><p>-&nbsp;&nbsp; If you are lactose intolerant or have any other lactose deficiency.</p><p>-&nbsp;&nbsp; If you are sucrose intolerant or have any other sucrose deficiency.</p><p>-&nbsp;&nbsp; If you are unable to comply with the instructions for use or cannot be monitored regularly.</p><p>-&nbsp;&nbsp; If you are pregnant, think you may be pregnant or are trying to become pregnant.</p><p>-&nbsp;&nbsp; If you have mild or moderate liver problems.</p><p>-&nbsp;&nbsp; Tell your doctor if any of the above applies to you.</p><p>-&nbsp;&nbsp; NeoMercazole can cause harm to an unborn baby. If you could get pregnant, use reliable contraception from the time you start treatment and during treatment.</p><p>Tell your doctor straight away if you develop fever or abdominal pain, which may be signs of inflammation of the pancreas (acute pancreatitis). NeoMercazole may need to be discontinued.</p><p><strong>c. Taking other medicines, herbal or dietary </strong><strong>supplements</strong></p><p>Please tell your doctor or pharmacist if you are taking or have recently taken any other medicines, including medicines obtained without a prescription, or the following:</p><p>- Theophylline used to treat asthma or breathing problems</p><p>-&nbsp;&nbsp; Medicines called anticoagulants, which are</p><p>used to thin the blood e.g. warfarin</p><p>-&nbsp;&nbsp; Steroids such as prednisolone.</p><p>-&nbsp;&nbsp; An antibiotic called erythromycin.</p><p>-&nbsp;&nbsp; A medicine for heart failure called digitalis.</p><p>-&nbsp;&nbsp; Medicines for high blood pressure called beta-blockers.</p><p><strong>d.</strong><strong> </strong><strong>Taking</strong><strong> NeoMercazole</strong><strong>&reg;</strong><strong>&nbsp;</strong><strong>with food and </strong><strong>drink</strong></p><p>- There are no known interactions with food or drink.</p><p><strong>e. Pregnancy and breast-feeding</strong></p><p>Your NeoMercazole&reg; treatment is important for you and may need to be continued during pregnancy but very rarely it can cause harm to a developing foetus. However, to reduce the possibility of any effects on your baby:</p><p>-&nbsp;&nbsp; Your doctor should prescribe the lowest dose possible.</p><p>-&nbsp;&nbsp; Your treatment may be discontinued three to four weeks before you are due to give birth.</p><p>-&nbsp;&nbsp; NeoMercazole&reg; can cause harm to an unborn baby</p><p>-&nbsp;&nbsp; If you could get pregnant, use reliable contraception from the time you start treatment and during treatment.</p><p>-&nbsp;&nbsp; If you are pregnant, think you may be pregnant or are planning to have a baby, tell your doctor straight away. Your treatment with NeoMercazole&reg; may need to be continued during pregnancy if the potential benefit outweighs the potential risk to you and your unborn baby.</p><p>-&nbsp;&nbsp; You should not breast-feed if you are using NeoMercazole&reg;. This is because small amounts may pass into the mother&rsquo;s milk.</p><p>Ask your doctor for advice before taking any medicine.</p><p><strong>f.</strong><strong> </strong><strong>Driving and using machines</strong></p><p>You can drive when taking NeoMercazole&reg;, but do not drive until you know how it affects you</p><p><strong>g.</strong><strong> </strong><strong>Important</strong><strong> </strong><strong>information </strong><strong>about some of the ingredients of NeoMercazole</strong><strong>&reg;</strong></p><p>NeoMercazole contains lactose and sucrose. If your doctor has told you that you have an intolerance to some sugars, contact your doctor before taking this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="AdministrationRoutesEn">3. How to use this product.</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Always take NeoMercazole&reg; exactly as your doctor has told you. You should check with</p><p>your doctor or pharmacist if you are not sure.</p><p>&bull;&nbsp; <strong>Instructions for proper use</strong></p><p>-&nbsp;&nbsp; You can take the tablets before, after or during meals</p><p>-&nbsp;&nbsp; The dosage will be decided by your doctor according to your individual needs, and may be changed at intervals during treatment.</p><p>-&nbsp;&nbsp; Your doctor may decide to add an additional tablet (l-thyroxine), to help control your condition.</p><p>-&nbsp;&nbsp; Each day&rsquo;s tablets may be divided into two (morning and evening) or three daily doses (morning, noon and night).</p><p>-&nbsp;&nbsp; Do not change the dosage without consulting your doctor first.</p><p>-&nbsp;&nbsp; Some improvement is usually felt within one to three weeks. However, full beneficial effects usually take four to eight weeks.</p><p>-&nbsp;&nbsp; If you take too many tablets or someone else accidentally takes your medicine, contact your doctor, pharmacist or the nearest hospital straight away.</p><p>-&nbsp;&nbsp; In order to maintain control of the thyroid gland, you may need to continue to take NeoMercazole&reg; tablets for several months. Your doctor will decide when treatment can be stopped. They may ask you to have occasional blood tests to help them to determine how you are responding to treatment.</p><p>Radio-iodine is another treatment for hyperthyroidism. If you need radioiodine treatment, your doctor will tell you to stop taking NeoMercazole&reg; temporarily.</p><p>&bull;&nbsp; <strong>Method and/or route(s) of</strong></p><p><strong>administration</strong></p><p>The tablets are to be taken by mouth.</p><p>&bull;&nbsp; <strong>Dosage,</strong><strong> </strong><strong>Frequency</strong><strong> </strong><strong>of administration </strong><strong>and duration of treatment</strong></p><p><strong>Adults and the elderly: </strong>the usual starting dose four to twelve tablets of 5 mg tablets daily. Once control is achieved your doctor will gradually reduce your dose to one to three tablets of 5 mg tablets each day.</p><p><strong>Children: </strong>the usual starting dose is three tablets of 5 mg tablets daily.</p><p><strong>a.&nbsp; </strong><strong>If you take more NeoMercazole</strong><strong>&reg;</strong></p><p>If you take more NeoMercazole than you should contact your doctor or nearest hospital emergency department immediately. Take the container and any remaining tablets with you.</p><p><strong>b.&nbsp; </strong><strong>If you forget to take NeoMercazole</strong><strong>&reg;</strong></p><p>If you forget to take NeoMercazole&reg; take the next dose as soon as you remember. If your next dose is due, take both doses together.</p><p>If you have any further questions of the use of this medicine ask your doctor or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsEn">4. Possible side effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Like all medicines, NeoMercazole</strong><strong>&reg; </strong><strong>can cause side effects, although not everybody </strong><strong>gets them.</strong></p><p><strong>Allergic reactions</strong></p><p>If you have an allergic reaction, stop taking NeoMercazole&reg; and see a doctor straight away. The signs may include: sudden rash, swelling or difficulty breathing.</p><p>Stop taking NeoMercazole&reg; and see a doctor straight away if you notice any of the following side effects:</p><p>-&nbsp;&nbsp; sore throat</p><p>-&nbsp;&nbsp; mouth ulcers</p><p>-&nbsp;&nbsp; high temperature or fever</p><p>-&nbsp;&nbsp; significant tiredness</p><p>-&nbsp;&nbsp; itching</p><p>-&nbsp;&nbsp; increased bruising or bleeding tendency</p><p>-&nbsp;&nbsp; you are feeling generally unwell or think that you may have an infection.</p><p>In addition, if you experience any of these symptoms while taking NeoMercazole&reg; you should also <strong>contact your doctor </strong><strong>immediately:</strong></p><p>&bull;&nbsp; Muscle pain or weakness.</p><p>&bull;&nbsp; Nerve pain.</p><p>&bull;&nbsp; Swelling of lymph nodes.</p><p>&bull;&nbsp; Swelling of glands in your mouth.</p><p>&bull;&nbsp; Feeling faint (low blood sugar).</p><p>&bull;&nbsp; Yellowing of your skin or whites of your eyes.</p><p>These could be signs of muscle problems, jaundice or inflammation of the liver and under medical supervision your doctor may want you to stop taking the medicine and carry out some blood tests on you.</p><p>Do not stop taking NeoMercazole&reg; until you have consulted your doctor. <strong>NeoMercazole</strong><strong>&reg; </strong><strong>can sometimes cause bone marrow depression. </strong>Some tests should be performed to check for bone marrow depression before restarting your treatment. Bone marrow depression causes a reduction in the number of blood cells and reduces the ability to fight infection. If it is not treated as soon as it is detected the condition can become</p><p>life-threatening. Neomercazole&reg;&nbsp; can also affect the liver (causing jaundice and inflammation of the liver) or the muscles. If you experience muscle aches or pains or notice yellowing of your skin or the whites of your eyes <strong>consult your doctor immediately </strong>as, under medical supervision, the drug should be stopped and blood tests performed. Other side effects include:</p><p>-&nbsp;&nbsp; feeling sick</p><p>-&nbsp;&nbsp; headache</p><p>-&nbsp;&nbsp; skin rashes, including urticaria (nettle rash)</p><p>-&nbsp;&nbsp; itching</p><p>-&nbsp;&nbsp; stomach upset</p><p>-&nbsp;&nbsp; painful joints.</p><p>The following side effects have also been reported:</p><p>-&nbsp;&nbsp; hair loss</p><p>loss of taste</p><p>-&nbsp;&nbsp; angioedema,- a serious allergic reaction</p><p>with symptoms that may include swollen tongue, lips, face or throat</p><p>-&nbsp;&nbsp; lung problems, with symptoms that include shortness of breath or cough</p><p>-&nbsp;&nbsp; kidney problems, with symptoms that include a reduction of the amount of urine passed, fluid retention and blood in the urine.</p><p>-&nbsp;&nbsp; Inflammation of the pancreas (acute pancreatitis).</p><p>If any of the side effects gets serious, or if you notice any side effects not listed in this leaflet, please tell your doctor, health care provider or pharmacist.</p>
            </div>
        </div>
    </div>
    <div class="col-lg-12 col-md-12 col-sm-6 col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsEn">5. How to store this product</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>Keep out of the reach and sight of children. Do not store above 25&deg;C. Store in the original container away from heat.</p><p>Do not use after the expiry date which is printed on the carton after EXP. The expiry date refers to the last day of that month. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. Further information</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsEn">a. What this product contains</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p>-&nbsp;&nbsp; The active substance is carbimazole</p><p>-&nbsp;&nbsp; The other ingredients are sucrose, lactose, acacia, talc, maize starch, magnesium stearate, gelatine and red iron oxide (E172)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsEn">b. What this product looks like and contents of the pack</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                NeoMercazole 5 mg tablets are pink circular biconvex tablets imprinted with ‘Neo 5’ on the obverse and plain on the reverse.
NeoMercazole® tablets are available in HDPE bottles with a polypropylene tamper-evident screw cap with integrated desiccant. Each bottle contains 100 Tablets.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingEn">c. Marketing Authorization Holder and Manufacturer</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                <p><strong>Manufacturer:</strong></p><p>Cenexi, 52, rue Marcel et Jacques Gaucher, 94120 Fontenay-sous-Bois, France.</p><p><strong>Marketing Authorization Holder: </strong>Amdipharm Limited, Temple Chambers, 3 Burlington Road, Dublin 4, Ireland.</p><p>Tel No: + 353 (0) 1 697 1640.</p><p>Fax No: + 353 (0) 1 697 1641.</p><p>Email: enquiries@advanzpharma.com</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteEn">d. This leaflet was last revised in {MM/YYYY}</label>
        </div>
        <div class="form-group">
            <br />
            <div class="m-l-60">
                05/2020
            </div>
        </div>
    </div>
</div>    </div>
    <div id="A-div" class="box-data">
<div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue  m-t-20 m-b-20 ltr">
                <i class="fa fa-info-circle"></i>&nbsp;
                <span style="font-size: large; background-color: rgb(245,245,245); color: rgb(51,51,51); "> نشرة الدواء تحت مراجعة الهيئة العامة للغذاء والدواء</span>
                <span style="font-size:small;">  (اقرأ هذه النشرة بعناية قبل البدء في استخدام هذا المنتج لأنه يحتوي على معلومات مهمة لك)</span>
            </div>
    <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr">

    </div>

</div>
<div class="clearfix rtl">
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="InventedNameAr">1. ما ھو هذا المستحضر وماھي دواعي استعماله</label>
        </div>
        <div class="form-group clearfix" style="float: right">
            <br />
            <p dir="RTL">دواء ﻧﻴﻮﻣﻴﺮﻛﺎزول&reg;&nbsp;ﻋﻠﻰ اﻟﻤﺎدة اﻟﻔﻌﺎﻟﺔ ﻛﺎرﺑﻴﻤﺎزول. ﻳﻨﺘﻤﻲ دواء ﻧﻴﻮﻣﻴﺮﻛﺎزول إﻟﻰ اﻟﻤﺠﻤﻮﻋﺔ</p><p dir="RTL">اﻟﺪواﺋﻴﺔ اﻟﻤﺴﻤﺎة ﻋﻮاﻣﻞ ﻋﻼج اﻟﻐﺪة اﻟﺪرﻗﻴﺔ.</p><p dir="RTL"><strong>&bull;</strong><strong> </strong><strong>دواﻋﻲ اﻻﺳﺘﺨﺪام</strong><strong>:</strong></p><p dir="RTL">ﻳﺴﺘﺨﺪم ﻧﻴﻮﻣﻴﺮﻛﺎزول&reg;&nbsp;ﻟﺘﻘﻠﻴﻞ ﺗﻜﻮن ﻫﺮﻣﻮﻧﺎت اﻟﻐﺪة اﻟﺪرﻗﻴﺔ ﻟﺪى اﻷﺷﺨﺎص اﻟﺬﻳﻦ ﻳﻌﺎﻧﻮن ﻣﻦ ﻏﺪة درﻗﻴﺔ ﻣﻔﺮﻃﺔ اﻟﻨﺸﺎط، وﻫﺬه</p><p dir="RTL">اﻟﺤﺎﻟﺔ ﺗﺴﻤﻰ ﻓﺮط ﻧﺸﺎط اﻟﻐﺪة اﻟﺪرﻗﻴﺔ.</p><p dir="RTL">ﻳﺴﺘﺨﺪم ﻧﻴﻮﻣﻴﺮﻛﺎزول&reg;&nbsp;أﻳ &nbsp;&nbsp;ﻀﺎ ﻓﻲ اﻟﺤﺎﻻت اﻷﺧﻄﺮ، ﻋﻠﻰ ﺳﺒﻴﻞ اﻟﻤﺜﺎل، ﻻﺳﺘﻌﺎدة اﻟﻮﻇﺎﺋﻒ اﻟﻄﺒﻴﻌﻴﺔ ﻟﻠﻐﺪة اﻟﺪرﻗﻴﺔ ﻗﺒﻞ</p><p dir="RTL">اﺳﺘﺌﺼﺎﻟﻬﺎ&nbsp;ﺟﺰﺋﻴﺎ&nbsp;ﻋﻦ ﻃﺮﻳﻖ اﻟﺠﺮاﺣﺔ، ﻛﻤﺎ ﻗﺪ ﻳﺴﺘﺨﺪم أﻳ &nbsp;&nbsp;ﻀﺎ ﻣﻊ أدوﻳﺔ أﺧﺮى ﻟﻌﻼج ﻓﺮط</p><p dir="RTL">ﻧﺸﺎط اﻟﻐﺪة اﻟﺪرﻗﻴﺔ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="form-group clearfix">
            <label class="h2" for="PrecautionsAr">2. ما الذي يجب عليك معرفته قبل استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">إذا ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ اﻟﺤﺴﺎﺳﻴﺔ ﺿﺪ ﻣﺎدة اﻟﻜﺎرﺑﻴﻤﺎزول أو أي ﻣﻦ ﻣﻜﻮﻧﺎت دواء</p><p dir="RTL">ﻧﻴﻮﻣﻴﺮﻛﺎزول.&reg;&nbsp;- إذا ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ اﻟﺤﺴﺎﺳﻴﺔ ﺗﺠﺎه أي أدوﻳﺔ أﺧﺮى ﻣﻦ اﻷدوﻳﺔ اﻟﻤﻀﺎدة ﻟﻠﻐﺪة</p><p dir="RTL">اﻟﺪرﻗﻴﺔ ﻣﺜﻞ اﻟﺜﻴﺎﻣﺎزول أو اﻟﻤﻴﺜﻴﻤﺎزول أو</p><p dir="RTL">اﻟﺒﺮوﺑﻴﻞ ﺛﻴﻮراﺳﻴﻞ.</p><p dir="RTL">- &nbsp;إذا ﻛﻨﺖ &nbsp;ﹸﺗﺮﺿﻌﻴﻦ رﺿﺎﻋﺔ ﻃﺒﻴﻌﻴﺔ. - إذا ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ اﺿﻄﺮاﺑﺎت ﺣﺎدة ﻓﻲ</p><p dir="RTL">اﻟﺪم. - إذا ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ اﺿﻄﺮاﺑﺎت ﺣﺎدة ﻓﻲ</p><p dir="RTL">اﻟﻜﺒﺪ. - &nbsp;إذا ﻛﻨﺖ ﻣﺼﺎﺑﺔﺑﺎﻟﺘﻬﺎب اﻟﺒﻨﻜﺮﻳﺎس</p><p dir="RTL">)اﻟﺘﻬﺎب اﻟﺒﻨﻜﺮﻳﺎس اﻟﺤﺎد( ﺑﻌﺪ ﺗﻨﺎوﻟﻚ</p><p dir="RTL">ﻟﻠﻜﺮﺑﻴﻤﺎزول أو اﻟﺜﻴﺎﻣﺎزول ﻓﻲ اﻟﻤﺎﺿﻲ.</p><p dir="RTL"><strong>ب</strong><strong>.</strong><strong> </strong><strong>ﻳﻨﺒﻐﻲ ﺗﻨﺎول ﻧﻴﻮﻣﻴﺮﻛﺎزول ﺑﻌﻨﺎﻳﺔ ﺷﺪﻳﺪة</strong><strong> </strong><strong>&reg;</strong></p><p dir="RTL">- إذا ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ ﺗﻮرم ﺑﺎﻟﺮﻗﺒﺔ ﻣﻦ اﻟﻨﻮع</p><p dir="RTL">اﻟﻤﺴﻤﻰ &quot;دراق داﺧﻞ اﻟﺼﺪر.&quot;</p><p dir="RTL">- إذا ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ ﺧﻤﻮد ﻧﻘﻲ اﻟﻌﻈﺎم. - إذا ﻛﻨﺖ ﺗﺘﻨﺎول اﻟﻴﻮد اﻹﺷﻌﺎﻋﻲ )ﺑﻌﻼج</p><p dir="RTL">-&nbsp;&nbsp;ﻣﺸﺎﻛﻞ اﻟﻐﺪة اﻟﺪرﻗﻴﺔ.( &nbsp;&nbsp;&nbsp;ﹰ</p><p dir="RTL">إذا ﻛﺎن اﻟﺤﻤﻞ أﻣﺮا ﻣﺤﺘﻤ</p><p dir="RTL">- إذا ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ اﻟﺤﺴﺎﺳﻴﺔ ﺗﺠﺎه اﻟﺜﻴﺎﻣﺎزول أو اﻟﻤﻴﺜﻴﻤﺎزول أو اﻟﺒﺮوﺑﻴﻞ</p><p dir="RTL">ﺛﻴﻮراﺳﻴﻞ )أدوﻳﺔ أﺧﺮى ﻟﻌﻼج اﻟﻐﺪة</p><p dir="RTL">اﻟﺪرﻗﻴﺔ.(</p><p dir="RTL">- إذا ﻛﻨﺖ ﻏﻴﺮ ﻗﺎدر ﻋﻠﻰ ﺗﺤﻤﻞ اﻟﻼﻛﺘﻮز أو</p><p dir="RTL">ﺗﻌﺎﻧﻲ ﻣﻦ أي ﻗﺼﻮر ﻓﻴﻤﺎ ﻳﺘﻌﻠﻖ ﺑﺎﻟﻼﻛﺘﻮز.</p><p dir="RTL">- إذا ﻛﻨﺖ ﻏﻴﺮ ﻗﺎدر ﻋﻠﻰ ﺗﺤﻤﻞ اﻟﺴﻜﺮوز أو ﺗﻌﺎﻧﻲ ﻣﻦ أي ﻗﺼﻮر ﻓﻴﻤﺎ ﻳﺘﻌﻠﻖ ﺑﺎﻟﺴﻜﺮوز - إذا ﻟﻢ ﺗﺴﺘﻄﻊ اﻻﻣﺘﺜﺎل ﻟﺘﻌﻠﻴﻤﺎت اﻻﺳﺘﺨﺪام</p><p dir="RTL">أو ﻛﺎن ﻻ ﻳﻤﻜﻦ ﻣﺮاﻗﺒﺘﻚ ﺑﺼﻔﺔ دورﻳﺔ. - &nbsp;إذا ﻛﻨﺖ ﺣﺎﻣ أو ﺗﻌﺘﻘﺪﻳﻦ أﻧﻚ ﻗﺪ ﺗﻜﻮﻧﻴﻦ</p><p dir="RTL">ﺣﺎﻣ أو ﺗﺤﺎوﻟﻴﻦ اﻟﺤﻤﻞ.</p><p dir="RTL">- إذا ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ ﻣﺸﺎﻛﻞ ﻃﻔﻴﻔﺔ أو ﻣﺘﻮﺳﻄﺔ ﺑﺎﻟﻜﺒﺪ.</p><p dir="RTL">- أﺧﺒﺮ ﻃﺒﻴﺒﻚ إذا ﻛﺎن أي ﻣﻤﺎ ﺳﺒﻖ ﻳﻨﻄﺒﻖ ﻋﻠﻰ ﺣﺎﻟﺘﻚ.</p><p dir="RTL">- ﻧﻴﻮﻣﺮﻛﺎزول ﻗﺪ ﻳﺘﺴﺒﺐ ﻓﻲ اﻟﻀﺮر ﻟﻠﺠﻨﻴﻦ. ﻳﺠﺐ اﺳﺘﺨﺪام وﺳﺎﺋﻞ ﻣﻨﻊ اﻟﺤﻤﻞ اﻟﻤﻮﺛﻮﻗﺔ</p><p dir="RTL">ﻣﻦ وﻗﺖ ﺑﺪء اﻟﻌﻼج وأﺛﻨﺎء اﻟﻌﻼج ﻓﻲ ﺣﺎل</p><p dir="RTL">وﺟﻮد اﻣﻜﺎﻧﻴﺔ ﻟﻠﺤﻤﻞ. - أﺧﺒﺮ ﻃﺒﻴﺒﻚ ﻋﻠﻰ اﻟﻔﻮر إذا ﻛﻨﺖ ﺗﻌﺎﻧﻲ ﻣﻦ اﻟﺤﻤﻰ أو آﻻم ﻓﻲ اﻟﺒﻄﻦ ، واﻟﺘﻲ ﻗﺪ ﺗﻜﻮن</p><p dir="RTL">ﻋﻼﻣﺎت اﻟﺘﻬﺎب اﻟﺒﻨﻜﺮﻳﺎس )اﻟﺘﻬﺎب اﻟﺒﻨﻜﺮﻳﺎس اﻟﺤﺎد.( ﻗﺪ ﺗﺤﺘﺎج إﻟﻰ وﻗﻒ</p><p>اﺳﺘﺨﺪام ﻧﻴﻮﻣﺮﻛﺎزول</p><p dir="RTL"><strong>ﻣﻜﻤﻼت</strong></p><p dir="RTL"><strong>ﻏﺬاﺋﻴﺔ</strong></p><p dir="RTL">ﻳﺮﺟﻰ إﺧﺒﺎر اﻟﻄﺒﻴﺐ أو اﻟﺼﻴﺪﻟﻲ ﺑﻤﺎ إذا ﻛﻨﺖ</p><p dir="RTL"><strong>ج-</strong> ﺗﺘﻨﺎول أو ﻗﺪ ﺗﻨﺎوﻟﺖ ﻣﺆﺧﺮا أي أدوﻳﺔ أﺧﺮى، ﺑﻤﺎ ﻓﻲ ذﻟﻚ اﻷدوﻳﺔ اﻟﺘﻲ ﺗﺘﻨﺎوﻟﻬﺎ دون وﺻﻔﺔ</p><p dir="RTL">ﻃﺒﻴﺔ أو أي ﻣﻤﺎ ﻳﻠﻲ: - اﻟﺜﻴﻮﻓﻴﻠﻴﻦ اﻟﺬي ﻳﺴﺘﺨﺪم ﻟﻌﻼج اﻟﺮﺑﻮ أو</p><p dir="RTL">ﻣﺸﺎﻛﻞ اﻟﺘﻨﻔﺲ. - اﻷدوﻳﺔ اﻟﻤﺴﻤﺎة ﺑﻤﻀﺎدات اﻟﺘﺠﻠﻂ اﺗﻲ</p><p dir="RTL">ﺗﺴﺘﺨﺪم ﻓﻲ ﺗﺮﻗﻴﻖ اﻟﺪم ﻣﺜﻞ اﻟﻮارﻓﺎرﻳﻦ.</p><p dir="RTL">- اﻷدوﻳﺔ اﻟﺴﺘﺮوﻳﺪﻳﺔ ﻣﺜﻞ اﻟﺒﺮﻳﺪﻧﻴﺴﻮﻟﻮن. - اﻟﻤﻀﺎد اﻟﺤﻴﻮي اﻟﻤﻌﺮوف ﺑﺎﺳﻢ</p><p dir="RTL">إﻳﺮﻳﺜﺮوﻣﻴﺴﻴﻦ. - أي أدوﻳﺔ ﺧﺎﺻﺔ ﺑﻤﺸﺎﻛﻞ اﻟﻘﻠﺐ اﻟﺘﻲ ﺗﺴﻤﻰ</p><p dir="RTL">دﻳﺠﺘﺎﻟﻴﺲ.</p><p dir="RTL">- أدوﻳﺔ ﻻرﺗﻔﺎع ﺿﻐﻂ اﻟﺪم ﻣﺜﻞ ﻣﺜﺒﻄﺎت ﺑﻴﺘﺎ.</p><p dir="RTL"><strong>د</strong><strong>-</strong><strong>ﺗﻨﺎول ﻧﻴﻮ ﻣﻴﺮﻛﺎزول</strong><strong>&reg;</strong><strong>&nbsp;</strong><strong>ﻣﻊ اﻷﻃﻌﻤﺔ</strong></p><p dir="RTL"><strong>واﻟﻤﺸﺮوﺑﺎت</strong></p><p dir="RTL">- ﻻ ﺗﻮﺟﺪ أي ﺗﻔﺎﻋﻼت ﻣﻌﺮوﻓﺔ ﻣﻊ اﻷدوﻳﺔ</p><p dir="RTL">واﻟﻤﺸﺮوﺑﺎت.</p><p dir="RTL"><strong>ﻫـ</strong><strong>-</strong><strong> </strong><strong>اﻟﺤﻤﻞ واﻟﺮﺿﺎﻋﺔ اﻟﻄﺒﻴﻌﻴﺔ</strong></p><p dir="RTL">ﻋﻘﺎر ﻧﻴﻮ ﻣﻴﺮﻛﺎزول&reg;&nbsp;ﺿﺮوري ﺑﺎﻟﻨﺴﺒﺔ إﻟﻴﻚ، وﻗﺪ ﺗﻀﻄﺮﻳﻦ إﻟﻰ اﻻﺳﺘﻤﺮار ﻓﻲ ﺗﻨﺎوﻟﻪ أﺛﻨﺎء اﻟﺤﻤﻞ، وﻟﻜﻨﻪ ﻧﺎدرا ﻣﺎ ﻳﺴﺒﺐ أي أﺿﺮار</p><p dir="RTL">ﻟﻸﺟ ﱠﻨﺔ. وﻣﻊ ﻫﺬا، ﻟﺘﻘﻠﻴﻞ اﺣﺘﻤﺎل ﺣﺪوث أي</p><p dir="RTL">آﺛﺎر ﻋﻠﻰ اﻟﺠﺴﻢ:</p><p dir="RTL">- ﻳﺠﺐ أن ﻳﺼﻒ اﻟﻄﺒﻴﺐ أﻗﻞ ﺟﺮﻋﺔ ﻣﻤﻜﻨﺔ. - ﻗﺪ ﻳﺘﻢ إﻳﻘﺎﻓﻚ ﻋﻦ ﺗﻨﺎول اﻟﺠﺮﻋﺎت ﻟﻤﺪة</p><p dir="RTL">ﺛﻼﺛﺔ أو أرﺑﻌﺔ أﺳﺎﺑﻴﻊ ﻗﻞ ﻣﻮﻋﺪ وﻻدﺗﻚ.</p><p dir="RTL">- ﻧﻴﻮﻣﺮﻛﺎزول ﻗﺪ ﻳﺘﺴﺒﺐ ﻓﻲ اﻟﻀﺮر ﻟﻠﺠﻨﻴﻦ. ﻳﺠﺐ اﺳﺘﺨﺪام وﺳﺎﺋﻞ ﻣﻨﻊ اﻟﺤﻤﻞ اﻟﻤﻮﺛﻮﻗﺔ</p><p dir="RTL">ﻣﻦ وﻗﺖ ﺑﺪء اﻟﻌﻼج وأﺛﻨﺎء اﻟﻌﻼج ﻓﻲ ﺣﺎل</p><p dir="RTL">وﺟﻮد اﻣﻜﺎﻧﻴﺔ ﻟﻠﺤﻤﻞ.</p><p dir="RTL">- إذا ﻛﻨﺖ ﺣﺎﻣﻼ ، او ﺗﻌﺘﻘﺪﻳﻦ أﻧﻚ ﺣﺎﻣﻞ أو ﺗﺨﻄﻄﻴﻦ ﻹﻧﺠﺎب ﻃﻔﻞ ، أﺧﺒﺮي ﻃﺒﻴﺒﻚ ﻋﻠﻰ</p><p dir="RTL">اﻟﻔﻮر.</p><p dir="RTL">ﻗﺪ ﺗﺤﺘﺎج إﻟﻰ ﻣﻮاﺻﻠﺔ ﻋﻼﺟﻚ ﻣﻊ ﻧﻴﻮﻣﺮﻛﺎزول أﺛﻨﺎء اﻟﺤﻤﻞ إذا ﻛﺎﻧﺖ اﻟﻔﺎﺋﺪة اﻟﻤﺤﺘﻤﻠﺔ ﺗﻔﻮق اﻟﺨﻄﺮ اﻟﻤﺤﺘﻤﻞ ﻋﻠﻴﻚ وﻋﻠﻰ</p><p dir="RTL">اﻟﺠﻨﻴﻦ.</p><p dir="RTL">-&nbsp;ﻻ ﻳﺠﺐ ﻋﻠﻴﻚ إرﺿﺎع ﻃﻔﻠﻚ ﻃﺒﻴﻌﻴﺎ&nbsp;ﻓﻲ ﺣﺎل اﺳﺘﺨﺪام ﻧﻴﻮ ﻣﻴﺮﻛﺎزول&reg;؛ وﻫﺬا ﻷﻧﻪ ﻗﺪ ﺗﻤﺮ</p><p dir="RTL">ﻛﻤﻴﺎت ﺻﻐﻴﺮة ﻣﻨﻪ إﻟﻰ ﺣﻠﻴﺐ اﻷم.</p><p dir="RTL">اﻃﻠﺐ اﻟﻨﺼﻴﺤﺔ ﻣﻦ اﻟﻄﺒﻴﺐ أو اﻟﺼﻴﺪﻟﻲ ﻗﺒﻞ</p><p dir="RTL">ﺗﻨﺎول أي دواء.</p><p>&nbsp;</p><p dir="RTL"><strong>و</strong><strong>-</strong><strong> اﻟﻘﻴﺎدة واﺳﺘﺨﺪام اﻵﻻت </strong>ﻳﻤﻜﻦ اﻟﻘﻴﺎدة أﺛﻨﺎء ﺗﻨﺎول ﻋﻘﺎر ﻧﻴﻮ ﻣﻴﺮﻛﺎزول &reg;، وﻟﻜﻦ ﻻ ﺗﺤﺎول اﻟﻘﻴﺎدة ﺣﺘﻰ ﺗﺘﻌﺮف ﻋﻠﻰ</p><p dir="RTL">ﻣﺪى ﺗﺄﺛﻴﺮه ﻋﻠﻴﻚ.</p><p dir="RTL"><strong>ز</strong><strong>-</strong><strong> </strong><strong>ﻣﻌﻠﻮﻣﺎت ﻫﺎﻣﺔ ﻋﻦ ﺑﻌﺾ ﻣﻜﻮﻧﺎت ﻧﻴﻮ</strong></p><p dir="RTL"><strong>ﻣﻴﺮﻛﺎزول</strong><strong>&reg;</strong></p><p dir="RTL">ﻳﺤﺘﻮي ﻧﻴﻮﻣﻴﺮﻛﺎزول ﻋﻠﻰ اﻟﻼﻛﺘﻮز واﻟﺴﻜﺮوز. إذا أﺧﺒﺮك ﻃﺒﻴﺒﻚ أﻧﻚ ﻗﺪ ﺗﻌﺎﻧﻲ</p><p dir="RTL">ﻣﻦ ﻓﺮط اﻟﺤﺴﺎﺳﻴﺔ ﻟﺒﻌﺾ اﻟﺴﻜﺮﻳﺎت،</p><p>ﻓﺎﺗﺼﻞ ﺑﺎﻟﻄﺒﻴﺐ ﻗﺒﻞ ﺗﻨﺎول ﻫﺬا اﻟﺪواء.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            https://localhost:44358/Dashboard
            <label class="h2" for="AdministrationRoutesAr">3. ماھي طريقة استعمال هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ﻋﻠﻴﻚ ﺗﻨﺎول ﻧﻴﻮ ﻣﻴﺮﻛﺎزول&nbsp; &reg;&nbsp;داﺋﻤﺎ ﺑﺤﺴﺐ إرﺷﺎدات اﻟﻄﺒﻴﺐ. ﻋﻠﻴﻚ اﺳﺘﺸﺎرة اﻟﻄﺒﻴﺐ أو</p><p dir="RTL">اﻟﺼﻴﺪﻟﻲ داﺋﻤﺎ إذا ﻟﻢ ﺗﻜﻦ ﻣﺘﺄﻛﺪا.</p><p dir="RTL"><strong>&bull;</strong><strong>&nbsp; ﺗﻌﻠﻴﻤﺎت اﻻﺳﺘﺨﺪام اﻟﻤﻨﺎﺳﺐ</strong></p><p dir="RTL">- ﻳﻤﻜﻨﻚ ﺗﻨﺎول اﻷﻗﺮاص ﻗﺒﻞ أو أﺛﻨﺎء أو ﺑﻌﺪ</p><p dir="RTL">اﻟﻮﺟﺒﺎت. - ﻳﻘﺮر ﻃﺒﻴﺒﻚ اﻟﺠﺮﻋﺔ وﻓﻘﺎ ﻻﺣﺘﻴﺎﺟﺎﺗﻚ</p><p dir="RTL">اﻟﻔﺮدﻳﺔ، وﻗﺪ ﺗﺘﻐﻴﺮ ﻋﻠﻰ ﻓﺘﺮت أﺛﻨﺎء اﻟﻌﻼج.</p><p dir="RTL">- ﻗﺪ ﻳﻘﺮر ﻃﺒﻴﺒﻚ إﺿﺎﻓﺔ ﻗﺮص آﺧﺮ -1) ﺛﻴﺮوﻛﺴﻴﻦ( ﻟﻠﻤﺴﺎﻋﺪة ﻋﻠﻰ اﻟﺘﺤﻜﻢ ﻓﻲ</p><p dir="RTL">ﺣﺎﻟﺘﻚ. - أﻗﺮاص اﻟﻴﻮم ﻳﻤﻜﻦ ﺗﻘﺴﻴﻤﻬﺎ ﻋﻠﻰ ﺟﺮﻋﺘﻴﻦ</p><p dir="RTL">)ﺻﺒﺎﺣﺎ وﻣﺴﺎء( أو ﺛﻼث ﺟﺮﻋﺎت ﻳﻮﻣﻴﺔ</p><p dir="RTL">)ﺻﺒﺎﺣﺎ وﻇﻬﺮا وﻣﺴﺎء(&nbsp;-<strong>&nbsp;</strong><strong>ﻻ</strong><strong>&nbsp;</strong><strong>ﺗﻐ</strong><strong>ﻴ</strong><strong></strong><strong>ﺮ</strong>&nbsp;اﻟﺠﺮﻋﺔ ﺑﺪون اﺳﺘﺸﺎرة اﻟﻄﺒﻴﺐ</p><p dir="RTL">أوﻻ. - ﻋﺎدة ﻳﻤﻜﻦ اﻟﺸﻌﻮر ﺑﺒﻌﺾ اﻟﺘﺤﺴﻦ ﺧﻼل</p><p dir="RTL">أﺳﺒﻮع إﻟﻰ ﺛﻼﺛﺔ أﺳﺎﺑﻴﻊ، إﻻ أن اﻵﺛﺎر اﻟﻤﺮﻏﻮﺑﺔ ﻋﺎدة ﻣﺎ ﺗﺴﺘﻐﺮق أرﺑﻌﺔ إﻟﻰ</p><p dir="RTL">ﺛﻤﺎﻧﻴﺔ أﺳﺎﺑﻴﻊ ﻟﻠﻈﻬﻮر. - إذا ﺗﻨﺎوﻟﺖ اﻟﻜﺜﻴﺮ ﻣﻦ اﻷﻗﺮاص أو ﺗﻨﺎول</p><p dir="RTL">ﺷﺨﺺ آﺧﺮ أﻗﺮاﺻﻚ، ﻓﺎﺗﺼﻞ ﺑﺎﻟﻄﺒﻴﺐ أو</p><p dir="RTL">اﻟﺼﻴﺪﻟﻲ أو أﻗﺮب ﻣﺴﺘﺸﻔﻰ ﻋﻠﻰ اﻟﻔﻮر. - ﻟﻠﺤﻔﺎظ ﻋﻠﻰ ﺗﺤﻜﻤﻚ ﻓﻲ اﻟﻐﺪة اﻟﺪرﻗﻴﺔ، ﻗﺪ ﺗﺤﺘﺎج إﻟﻰ اﻻﺳﺘﻤﺮار ﻓﻲ ﺗﻨﺎول أﻗﺮاص ﻧﻴﻮ ﻣﻴﺮﻛﺎزول&reg;&nbsp;ﻟﻌﺪة أﺷﻬﺮ. ﺳﻴﻘﺮر ﻃﺒﻴﺒﻚ ﻣﺘﻰ</p><p dir="RTL">ﻳﻤﻜﻦ إﻳﻘﺎف اﻟﻌﻼج. ﻗﺪ ﻳﻄﻠﺐ ﻣﻨﻚ ﻋﻤﻞ ﺑﻌﺾ ﻓﺤﻮﺻﺎت اﻟﺪم وﻳﻘﺮر ﻣﺪى</p><p dir="RTL">اﺳﺘﺠﺎﺑﺘﻚ ﻟﻠﻌﻼج. - اﻟﻴﻮد اﻹﺷﻌﺎﻋﻲ ﻣﻦ اﻷدوﻳﺔ اﻷﺧﺮى</p><p dir="RTL">اﻟﻤﺴﺘﺨﺪﻣﺔ ﻓﻲ ﻋﻼج ﺣﺎﻟﺔ ﻓﺮط ﻧﺸﺎط اﻟﻐﺪة اﻟﺪرﻗﻴﺔ. إذا ﻛﻨﺖ ﺗﺤﺘﺎج إﻟﻰ اﻟﻌﻼج ﺑﺎﻟﻴﻮد اﻹﺷﻌﺎﻋﻲ، ﻓﺴﻴﻄﻠﺐ ﻣﻨﻚ اﻟﻄﺒﻴﺐ</p><p dir="RTL">اﻟﺘﻮﻗﻒ ﻋﻦ ﺗﻨﺎول ﻧﻴﻮﻣﻴﺮﻛﺎزول &reg;&nbsp;ﻣﺆﻗﺘﺎ.</p><p><strong>&bull; &nbsp;ﻃﺮﻳﻘﺔ و/أو ﻣﺴﺎر أﺧﺬ اﻟﺪواء:</strong></p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="SideEffectsAr">4. الأعراض الجانبية المحتملة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>ﻣﺜﻞ</strong><strong>&nbsp;</strong><strong>ﻛﻞ</strong><strong>&nbsp;</strong><strong>ا</strong><strong>ﻷدوﻳﺔ،</strong><strong>&nbsp;</strong><strong>ﻳﻤﻜﻦ</strong><strong>&nbsp;</strong><strong>أن</strong><strong>&nbsp;</strong><strong>ﻳﺴ</strong><strong>ﺒ</strong><strong></strong><strong>ﺐ</strong><strong>&nbsp;</strong><strong>ﻧﻴﻮ</strong><strong>&nbsp;</strong><strong>&nbsp;&nbsp;&nbsp; ﻣﻦ</strong></p><p dir="RTL"><strong>ﻣﻴﺮﻛﺎزول ﺑﻌﺾ اﻵﺛﺎر اﻟﺠﺎﻧﺒﻴﺔ ﺑﺎﻟﺮﻏﻢ</strong></p><p dir="RTL"><strong>أﻧﻬﺎ ﻻ ﺗﺼﻴﺐ اﻟﺠﻤﻴﻊ ﺗﻔﺎﻋﻼت اﻟﺤﺴﺎﺳﻴﺔ</strong></p><p dir="RTL">إذا ﺣﺪث ﻟﻚ أي رد ﻓﻌﻞ ﺗﺤﺴﺴﻲ، ﻓﺘﻮﻗ &nbsp;ﻒ</p><p dir="RTL">ﻋﻦ ﺗﻨﺎول ﻧﻴﻮ ﻣﻴﺮﻛﺎزول&reg;&nbsp;واذﻫﺐ إﻟﻰ اﻟﻄﺒﻴﺐ</p><p dir="RTL">ﻋﻠﻰ&nbsp;اﻟﻔﻮر.&nbsp;ﻗﺪ ﺗﺸﻤﻞ اﻟﻌﻼﻣﺎت:&nbsp;ﻃﻔﺤﺎ ﻣﻔﺎﺟﯩﺎ،</p><p dir="RTL">أو ﺗﻮرﻣﺎ، أو ﺻﻌﻮﺑﺔ ﻓﻲ اﻟﺘﻨﻔﺲ. ﺗﻮﻗ &nbsp;ﻒ ﻋﻦ ﺗﻨﺎول ﻧﻴﻮ ﻣﻴﺮﻛﺎزول&reg;&nbsp;واذﻫﺐ إﻟﻰ اﻟﻄﺒﻴﺐ ﻓﻮرا إذا ﻻﺣﻈﺖ أﻳﺎ ﻣﻦ اﻵﺛﺎر اﻟﺠﺎﻧﺒﻴﺔ</p><p dir="RTL">اﻟﺘﺎﻟﻴﺔ: - اﻟﺘﻬﺎب اﻟﺤﻠﻖ - ﻗﺮﺣﺔ اﻟﻔﻢ</p><p dir="RTL">- ارﺗﻔﺎع درﺟﺔ اﻟﺤﺮارة أو اﻟﺤﻤﻰ</p><p dir="RTL">- اﻟﺘﻌﺐ اﻟﺸﺪﻳﺪ</p><p dir="RTL">- ﺣﻜﺔ - ﻛﺪﻣﺎت أو اﺣﺘﻤﺎل اﻟﻨﺰﻳﻒ</p><p dir="RTL">- اﻟﺸﻌﻮر ﺑﺎﻟﺘﻌﺐ ﺑﺸﻜﻞ ﻋﺎم أو ﺗﻌﺘﻘﺪ أﻧﻚ</p><p dir="RTL">ﻣﺼﺎب ﺑﻌﺪوى</p><p dir="RTL">ﺑﺎﻹﺿﺎﻓﺔ إﻟﻰ ذﻟﻚ، إذا واﺟﻬﺖ أﻳﺎ ﻣﻦ ﻫﺬه</p><p dir="RTL">اﻷﻋﺮاض أﺛﻨﺎء ﺗﻨﺎول ﻧﻴﻮ ﻣﻴﺮﻛﺎزول&reg;،<strong> </strong><strong>ﻓﻴﺠﺐ</strong></p><p dir="RTL"><strong>ﻋﻠﻴﻚ أﻳﻀﺎ اﻻﺗﺼﺎل ﺑﺎﻟﻄﺒﻴﺐ ﻋﻠﻰ اﻟﻔﻮر</strong><strong>:</strong></p><p dir="RTL">&bull; &nbsp;آﻻم اﻟﻌﻀﻼت أو ﺿﻌﻔﻬﺎ.</p><p dir="RTL">&bull; &nbsp;آﻻم اﻷﻋﺼﺎب.</p><p dir="RTL">&bull; ﺗﻮرم اﻟﻌﻘﺪ اﻟﻠﻴﻤﻔﺎوﻳﺔ.</p><p dir="RTL">&bull; &nbsp;ﺗﻮرم اﻟﻐﺪد ﻓﻲ ﻓﻤﻚ.</p><p dir="RTL">&bull; &nbsp;اﻟﺸﻌﻮر ﺑﺎﻹﻏﻤﺎء )اﻧﺨﻔﺎض ﻧﺴﺒﺔ اﻟﺴﻜﺮ</p><p dir="RTL">ﻓﻲ اﻟﺪم.(</p><p dir="RTL">&bull; &nbsp;اﺻﻔﺮار ﺑﺸﺮﺗﻚ أو ﺑﻴﺎض ﻋﻴﻨﻴﻚ.</p><p dir="RTL">ﻗﺪ ﺗﻜﻮن ﻫﺬه ﻋﻼﻣﺎت ﻋﻠﻰ ﻣﺸﺎﻛﻞ ﻓﻲ اﻟﻌﻀﻼت، واﻟﻴﺮﻗﺎن أو اﻟﺘﻬﺎب اﻟﻜﺒﺪ، وﺗﺤﺖ إﺷﺮاف ﻃﺒﻲ ﻗﺪ ﻳﻄﻠﺐ ﻣﻨﻚ اﻟﻄﺒﻴﺐ اﻟﺘﻮﻗﻒ ﻋﻦ ﺗﻨﺎول اﻟﺪواء وإﺟﺮاء ﺑﻌﺾ ﻓﺤﻮﺻﺎت اﻟﺪم</p><p dir="RTL">ﻋﻠﻴﻚ.</p><p dir="RTL">ل<strong>ا ﺗﺘﻮﻗﻒ ﻋﻦ ﺗﻨﺎول ﻧﻴﻮ ﻣﻴﺮﻛﺎزول</strong><strong>&reg;</strong><strong>&nbsp;</strong><strong>ﺣﺘﻰ</strong> <strong>ﺗﺴﺘﺸﻴﺮ ﻃﺒﻴﺒﻚ</strong><strong>.</strong><strong> </strong><strong>ﻳﻤﻜﻦ أن ﻳﺴﺒﺐ ﻧﻴﻮ</strong></p><p dir="RTL"><strong>ﻣﻴ</strong><strong>ﺮ</strong><strong>ﻛﺎزول</strong><strong>&reg;</strong><strong>&nbsp;</strong><strong>أﺣﻴﺎ</strong><strong>ﻧ</strong><strong>ﺎ</strong><strong> </strong><strong>&nbsp;ﺧﻤﻮل ﻧﺨﺎع اﻟﻌﻈﻢ</strong><strong>.</strong><strong> </strong><strong>ﻳﺠﺐ</strong><strong> </strong>إﺟﺮاء ﺑﻌﺾ اﻻﺧﺘﺒﺎرات ﻟﻠﺘﺤﻘﻖ ﻣﻦ<strong> </strong><strong>ﺣﺎﻟﺔ</strong></p><p dir="RTL"><strong>ﺧﻤﻮل ﻧﺨﺎع</strong> اﻟﻌﻈﺎم ﻗﺒﻞ اﻟﺒﺪء ﻓﻲ اﻟﻌﻼج.<strong> </strong>ﻳﺴﺒﺐ<strong> ﺧﻤﻮل ﻧﺨﺎع</strong> اﻟﻌﻈﺎم اﻧﺨﻔﺎﺿﺎ ﻓﻲ ﻋﺪد ﺧﻼﻳﺎ اﻟﺪم وﻳﻘﻠﻞ ﻣﻦ اﻟﻘﺪرة ﻋﻠﻰ ﻣﻘﺎوﻣﺔ</p><p dir="RTL">اﻟﻌﺪوى. إذا ﻟﻢ ﻳﺘﻢ ﻋﻼﺟﻪ ﺑﻤﺠﺮد اﻛﺘﺸﺎﻓﻪ، ﻳﻤﻜﻦ أن ﺗﺼﺒﺢ اﻟﺤﺎﻟﺔ ﻣﻬ ﹺﺪدة ﻟﻠﺤﻴﺎة. ﻳﻤﻜﻦ أن ﻳﺆﺛﺮ ﻧﻴﻮ ﻣﻴﺮﻛﺎزول&reg;&nbsp;أﻳﻀﺎ ﻋﻠﻰ اﻟﻜﺒﺪ</p><p dir="RTL">)ﻳﺴﺒﺐ اﻟﻴﺮﻗﺎن واﻟﺘﻬﺎب اﻟﻜﺒﺪ( أو اﻟﻌﻀﻼت. إذا ﺷﻌﺮت ﺑﺄﻟﻢ ﻓﻲ اﻟﻌﻀﻼت أو آﻻم أو</p><p dir="RTL">ﻻﺣﻈﺖ اﺻﻔﺮار ﺑﺸﺮﺗﻚ أو ﺑﻴﺎض ﻋﻴﻨﻴﻚ، <strong>ﻓ</strong><strong>ﺎﺳ</strong><strong>ﺘ</strong><strong>ﺸ</strong><strong>ﺮ</strong><strong>&nbsp;</strong><strong>ﻃﺒﻴﺒﻚ</strong><strong>&nbsp;</strong><strong>ﻓﻮر</strong><strong></strong><strong>ا</strong><strong>،</strong>&nbsp;ﻓﺘ&nbsp;&nbsp;ﺤ&nbsp;&nbsp;ﺖ&nbsp;اﻹﺷﺮاف<strong>&nbsp;</strong>اﻟﻄﺒﻲ، ﻳﺠﺐ إﻳﻘﺎف اﻟﺪواء وإﺟﺮاء ﻓﺤﻮﺻﺎت</p><p dir="RTL">اﻟﺪم.</p><p dir="RTL">ﺗﺘﻀﻤﻦ اﻵﺛﺎر اﻟﺠﺎﻧﺒﻴﺔ اﻷﺧﺮى:</p><p dir="RTL">- اﻟﺸﻌﻮر ﺑﺎﻟﺘﻌﺐ - ﺻﺪاع اﻟﺮأس</p><p dir="RTL">- اﻟﻄﻔﺢ اﻟﺠﻠﺪي، ﺑﻤﺎ ﻓﻲ ذﻟﻚ اﻟﺸﺮى )ﻃﻔﺢ</p><p dir="RTL">اﻟﻘﺮاص(</p><p dir="RTL">- اﻟﺤﻜﺔ - اﺿﻄﺮاب اﻟﻤﻌﺪة - أﻟﻢ اﻟﻤﻔﺎﺻﻞ</p><p dir="RTL">ﻛﻤﺎ ﺗﻢ اﻹﺑﻼغ ﻋﻦ اﻵﺛﺎر اﻟﺠﺎﻧﺒﻴﺔ اﻟﺘﺎﻟﻴﺔ:</p><p dir="RTL">- ﺗﺴﺎﻗﻂ اﻟﺸﻌﺮ - ﻓﻘﺪان اﻹﺣﺴﺎس ﺑﺎﻟﺘﺬوق</p><p dir="RTL">- اﻟﻮذﻣﺔ اﻟﻮﻋﺎﺋﻴﺔ - رد ﻓﻌﻞ ﺗﺤﺴﺴﻲ ﺧﻄﻴﺮ ﻣﻊ أﻋﺮاض ﻗﺪ ﺗﺸﻤﻞ ﺗﻀﺨﻢ اﻟﻠﺴﺎن أو</p><p dir="RTL">اﻟﺸﻔﺘﻴﻦ أو اﻟﻮﺟﻪ أو اﻟﺤﻠﻖ.</p><p dir="RTL">- ﻣﺸﺎﻛﻞ ﻓﻲ اﻟﺮﺋﺔ، ﻣﻊ أﻋﺮاض ﺗﺘﻀﻤﻦ .</p><p dir="RTL">ﻣﺸﺎﻛﻞ ﻓﻲ اﻟﻜﻠﻰ: ﺗﺘﻀﻤﻦ اﻻﻋﺮاض اﻟﺘﻲ</p><p dir="RTL">ﺗﺸﻤﻞ ﺧﻔﺾ ﻛﻤﻴﺔاﻟﺒﻮل اﻟﺘﻲ ﺗﻤﺮ ﻋﺒﺮ</p><p dir="RTL">اﻟﻜﻠﻰ , واﺣﺘﺒﺎس اﻟﺴﻮاﺋﻞ واﻟﺪم ﻓﻲ اﻟﺒﻮل. - اﻟﺘﻬﺎب اﻟﺒﻨﻜﺮﻳﺎس )اﻟﺘﻬﺎب اﻟﺒﻨﻜﺮﻳﺎس</p><p dir="RTL">اﻟﺤﺎد.(</p><p dir="RTL">إذا ﺳﺎءت ﺣﺎﻟﺔ أي ﻣﻦ ﺗﻠﻚ اﻷﻋﺮاض اﻟﺠﺎﻧﺒﻴﺔ، أو إذا ﻻﺣﻈﺖ أي أﻋﺮاض ﺟﺎﻧﺒﻴﺔ ﻏﻴﺮ ﻣﺪرﺟﺔ ﻓﻲ ﻫﺬه اﻟﻨﺸﺮة، ﻳﺮﺟﻰ إﺧﺒﺎر</p><p dir="RTL">ﻃﺒﻴﺒﻚ أو ﻣﻘ ﹺﺪم اﻟﺮﻋﺎﻳﺔ اﻟﺼﺤﻴﺔ أو اﻟﺼﻴﺪﻟﻲ</p>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label class="h2" for="StorageConditionsAr">5. طريقة تخزين المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">ﻳﺤﻔﻆ ﺑﻌﻴﺪا ﻋﻦ ﻣﺘﻨﺎول وﺑﺼﺮ اﻷﻃﻔﺎل. ﻻ &nbsp;&nbsp;ﻳﺤﻔﻆ ﻓﻲ درﺟﺔ ﺣﺮارة أﻋﻠﻰ ﻣﻦ 25 درﺟﺔ ﻣﺌﻮﻳﺔ. وﻳﺤﻔﻆ ﻓﻲ ﻋﺒﻮﺗﻪ اﻷﺻﻠﻴﺔ ﺑﻌﻴﺪا ﻋﻦ</p><p dir="RTL">اﻟﺤﺮارة. &nbsp;ﻻ &nbsp;&nbsp;ﻳﺴﺘﺨﺪم ﺑﻌﺪ ﺗﺎرﻳﺦ اﻧﺘﻬﺎء اﻟﺼﻼﺣﻴﺔ اﻟﻤﻄﺒﻮع ﻋﻠﻰ اﻟﻜﺮﺗﻮن ﺑﻌﺪ ﻛﻠﻤﺔ .EXP ﻳﺸﻴﺮ ﺗﺎرﻳﺦ اﻧﺘﻬﺎء اﻟﺼﻼﺣﻴﺔ إﻟﻰ آﺧﺮ ﻳﻮم ﻓﻲ ذﻟﻚ</p><p dir="RTL">اﻟﺸﻬﺮ. ﻳﺠﺐ ﻋﺪم اﻟﺘﺨﻠﺺ ﻣﻦ اﻷدوﻳﺔ ﻋﻦ ﻃﺮﻳﻖ ﻣﻴﺎه اﻟﺼﺮف أو اﻟﻨﻔﺎﻳﺎت اﻟﻤﻨﺰﻟﻴﺔ. اﺳﺄل اﻟﺼﻴﺪﻟﻲ ﻋﻦ ﻛﻴﻔﻴﺔ اﻟﺘﺨﻠﺺ ﻣﻦ اﻷدوﻳﺔ اﻟﺘﻲ ﻟﻢ ﺗﻌﺪ ﻣﻄﻠﻮﺑﺔ. ﻣﻦ ﺷﺄن ﻫﺬه اﻟﺘﺪاﺑﻴﺮ أن ﺗﺴﺎﻋﺪ ﻋﻠﻰ</p><p dir="RTL">ﺣﻤﺎﻳﺔ اﻟﺒﻴﺌﺔ.</p>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: right">6. معلومات أخرى</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="IngredientsAr">أ‌. على ماذا يحتوي هذا المستحضر</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL">أ. ﻣﻌﻠﻮﻣﺎت ﺣﻮل ﻣﻴﺮﻛﺎزول:&reg;&nbsp;- اﻟﻤﺎدة اﻟﻔﻌﺎﻟﺔ ﻫﻲ ﻛﺎرﺑﻴﻤﺎزول</p><p dir="RTL">- اﻟﻤﻜﻮﻧﺎت اﻷﺧﺮى ﻫﻲ ﺳﻜﺮوز، ﻻﻛﺘﻮز، أﻛﺎﺳﻴﺎ، اﻟﺘﻠﻚ، ﻧﺸﺎ اﻟﺬرة، ﺳﺘﻴﺮات اﻟﻤﺎﻏﻨﺴﻴﻮم، اﻟﺠﻴﻼﺗﻴﻦ وأﻛﺴﻴﺪ اﻟﺤﺪﻳﺪ</p><p dir="RTL">اﻷﺣﻤﺮ .(E172)</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ShapeAndContentsAr">ب‌. كيف يبدو شكل هذا المستحضر وماهي محتويات العلبة</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL" style="text-align:right">ب. ﻣﺎ ﻳﺒﺪو ﻋﻠﻴﻪ ﻧﻴﻮ ﻣﻴﺮﻛﺎزول&reg;&nbsp;وﻣﺤﺘﻮﻳﺎﺗﻪ. أﻗﺮاص ﻧﻴﻮ ﻣﻴﺮﻛﺎزول&reg;&nbsp;5 ﻣﻠﻐﻢ ﻫﻲ ﻋﺒﺎرة ﻋﻦ ﻗﺮص وردي، داﺋﺮي، ﺛﻨﺎﺋﻲ اﻟﺘﺤﺪب، ﻣﻄﺒﻮع ﻋﻠﻴﻪ 5&quot; &quot;Neo ﻋﻠﻰ أﺣﺪ اﻷوﺟﻪ وﺧﺎ ﹴل ﻣﻦ</p><p dir="RTL" style="text-align:right">اﻟﻮﺟﻪ اﻵﺧﺮ. ﺗﺘﻮاﻓﺮ اﻗﺮاص ﻧﻴﻮﻣﻴﺮﻛﺎزول ﻓﻲ ﻗﻮارﻳﺮ ﻣﺼﻨﻮﻋﺔ ﻣﻦ ﻣﺎدة ﺑﻮﻟﻲ اﻳﺜﻴﻠﻴﻦ ﻋﺎﻟﻲ اﻟﻜﺜﺎﻓﺔ و ﻣﻐﻠﻘﺔ ﺑﻐﻄﺎء ﻣﺼﻨﻮع ﻣﻦ ﺑﻮﻟﻲ ﺑﺮوﺑﻴﻠﻴﻦ ﻛﺎﺷﻒ ﻟﻠﺘﻼﻋﺐ و ﻳﺤﺘﻮي ﻋﻠﻰ ﻣﺎدة ﻣﺠﻔﻔﺔ</p><p style="text-align:right">ﺗﺤﺘﻮي ﻛﻞ ﻋﺒﻮة ﻋﻠﻰ 100 ﻗﺮص</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="ManufacturingAndMarketingAr">ت‌. الشركة المصنعة ومالك حق التسويق</label>
        </div>
        <div class="m-r-60">
            <p dir="RTL"><strong>اﻟﺸﺮﻛﺔ اﻟﻤﺼﻨﻌﺔ</strong><strong>:</strong></p><p>Cenexi, 52, rue Marcel et Jacques</p><p>Gaucher, 94120 Fontenay-sous-Bois, France.</p><p><strong>:اﻟﺘﺴﻮﻳﻖ ﺗﺼﺮﻳﺢ ﺣﺎﻣﻞ </strong>Amdipharm Limited, Temple Chambers, 3 Burlington Road, Dublin 4, Ireland.</p><p>+ 353 (0) 1 697 1640 :رﻗﻢ ﻫﺎﺗﻒ</p><p dir="RTL">ﻓﺎﻛﺲ رﻗﻢ: 1641 697 1 (0) 353 + اﻟﺒﺮﻳﺪ اﻹﻟﻜﺘﺮوﻧﻲenquiries@advanzpharma.com:</p>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label class="h2" for="RevisionNoteAr">ث‌. تمت مراجعة هذه النشرة في التاريخ الذي تمت فيه مراجعة النشرة بالشهر والسنة</label>
        </div>
        <div class="m-r-60">
            2020/05
        </div>
    </div>
</div>
    </div>
    <div id="M-div" class="box-data">


    <div class="p-20 text-center font-22">
            <div class="p-10 bg-light-blue font-15 m-t-20 m-b-20 ltr"><i class="fa fa-info-circle"></i>&nbsp;Read this leaflet carefully before you start using this product as it contains important information for you</div>
    </div>
<div class="row clearfix ltr">

    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="MedicinalName">1. NAME OF THE MEDICINAL PRODUCT </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                NeoMercazole® 5mg Tablets
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="QualitativeQuantitativeComposition">2. QUALITATIVE AND QUANTITATIVE COMPOSITION </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Each NeoMercazole® 5mg tablet contains carbimazole Ph. Eur. 5mg.
For a full list of excipients see section 6.1

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="DosageForm">3. PHARMACEUTICAL FORM </label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                5 mg Tablet: Pink, circular, biconvex tablet, imprinted with ‘Neo 5’ on the obverse and plain on the reverse.
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">4. CLINICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="TherapeuticIndications">4.1 Therapeutic Indications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NeoMercazole<sup>&reg;</sup> is an anti-thyroid agent. It is indicated in adults and children in all conditions where reduction of thyroid function is required.</p><p>Such conditions are:</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Hyperthyroidism.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Preparation for thyroidectomy in hyperthyroidism.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Therapy prior to and post radio-iodine treatment.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PosologyAndMethodAdministration">4.2 Posology And Method Administration</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Posology</em></p><p>NeoMercazole<sup>&reg;</sup> should only be administered if hyperthyroidism has been confirmed by laboratory tests.</p><p><strong><u>&nbsp;</u></strong></p><p>Adults:</p><p>The initial dose is in the range 20 mg to 60 mg (four to twelve 5 mg tablets), per day taken as two to three divided doses. The regular checking of thyroid function is recommended and dose should be titrated against thyroid function until the patient is euthyroid in order to reduce the risk of over-treatment and resultant hypothyroidism.</p><p>&nbsp;</p><p>Subsequent therapy may then be administered in one of two ways.</p><p>&nbsp;</p><p>&nbsp;</p><p>Maintenance regimen:</p><p>Final dosage is usually in the range 5 mg to 15 mg (one to three 5 mg tablets) per day, which may be taken as a single daily dose, preferably with meals. Therapy should be continued for at least six months and up to 18&nbsp;months. Serial thyroid function monitoring is recommended, together with appropriate dosage modification in order to maintain a euthyroid state.</p><p>&nbsp;</p><p>Blocking-replacement regimen:</p><p>Dosage is maintained at the initial level, i.e. 20 mg to 60 mg (four to twelve tablets of 5 mg tablets) per day, and supplemental L-thyroxine, 50 microgram to 150 microgram per day, is administered concomitantly, in order to prevent hypothyroidism. Therapy should be continued for at least six months and up to eighteen months. Where a single dosage of less than 20&nbsp;mg is recommended, it is intended that carbimazole 5 mg tablets should be taken.</p><p>&nbsp;</p><p><em>Special populations:</em></p><p><strong>&nbsp;</strong></p><p>Elderly</p><p>No special dosage regimen is required, but care should be taken to observe the contraindications and warnings as it has been reported that the risk of a fatal outcome to neutrophil dyscrasia (e.g. neutropenia) may be greater in the elderly (aged 65 or over).</p><p>&nbsp;</p><p>Paediatric population</p><p>Use in children and adolescents (3 to 17 years of age)</p><p>The usual initial daily dose is 15 mg per day adjusted according to response.</p><p>Use in children (2 years of age and under)</p><p>&nbsp;</p><p>Safety and efficacy of carbimazole in children below 2 years of age have not been evaluated systematically. Use of carbimazole in children below 2 years of age is therefore not recommended.</p><p>&nbsp;</p><p><em>Route of administration</em></p><p>For oral administration only.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Contraindications">4.3 Contraindications</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Hypersensitivity to the active substance or to any of the excipients listed in section 6.1.
Serious, pre-existing haematological conditions.
Severe hepatic insufficiency

•	NeoMercazole® tablets are contraindicated in patients with a previous history of adverse reactions to carbimazole, thiamazole or to any of the excipients listed in section 6.1.
•	Breast feeding (see section 4.6).
•	Patients with a history of acute pancreatitis after administration of carbimazole or its active metabolite thiamazole.

            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialWarnings">4.4. Special warnings and precautions for use</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Bone marrow depression including neutropenia, eosinophilia, leucopenia and agranulocytosis has been reported. As fatal cases of agranulocytosis with carbimazole have been reported and early treatment of agranulocytosis is essential, it is important that patients should always be warned about the onset of sore throats, bruising or bleeding, mouth ulcers, fever, malaise and should be instructed to stop the drug and to seek medical advice immediately. In such patients white blood cell counts should be performed, particularly where there is any clinical evidence of infection.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Rare cases of pancytopenia/aplastic anaemia, isolated thrombocytopenia and very rare cases of haemolytic anaemia have been reported (see section 4.8).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Following the onset of any signs and symptoms of hepatic disorder (pain in the upper abdomen, anorexia, general pruritus) in patients, the drug should be stopped and liver function tests performed immediately. Early withdrawal of the drug will increase the chance of complete recovery.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NeoMercazole<sup>&reg;</sup> tablets should be used with caution in patients with mild-moderate hepatic insufficiency. If abnormal liver function is discovered, the treatment should be stopped. The half-life may be prolonged due to the liver disorder.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; NeoMercazole<sup>&reg;</sup> should be stopped temporarily at the time of administration of radio-iodine (to avoid thyroid crisis).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Patients unable to comply with the instructions for use or who cannot be monitored regularly should not be treated with NeoMercazole.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Regular full blood count checks should be carried out in patients who may be confused or have a poor memory. Special precaution is recommended in the case of concurrent administration of medicinal products capable of inducing agranulocytosis.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There have been post-marketing reports of acute pancreatitis in patients receiving carbimazole or its active metabolite thiamazole. In case of acute pancreatitis, carbimazole should be discontinued immediately. Carbimazole must not be given to patients with a history of acute pancreatitis after administration of carbimazole or its active metabolite thiamazole. Re-exposure may result in recurrence of acute pancreatitis, with decreased time to onset</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Precaution should be taken in patients with intrathoracic goiter, which may worsen during initial treatment with NeoMercazole<sup>&reg;</sup>. Tracheal obstruction may occur due to intrathoracic goiter.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Should the volume of the goiter increase, the dose of NeoMercazole<sup>&reg;</sup> should not be increased, since growth in volume is more likely to occur following overdosing of the preparation.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The use of carbimazole in non-pregnant women of childbearing potential should be based on individual risk/benefit assessment (see section 4.6).</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; There is a risk of cross-allergy between carbimazole, the active metabolite thiamazole (methimazole) and propylthiouracil.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Not to be administered if hyperthyroidism has not been confirmed by laboratory tests.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Since carbimazole is a vitamin K antagonist, the effect of anticoagulants could be intensified. An accurate control with regards to the anticoagulant dosage is required as hyperthyroid patients receiving treatment with carbimazole become euthyroid; additional monitoring of prothrombin time/international normalised ratio (PT/INR) should be considered, especially before surgical procedures. Carbimazole administration may itself, rarely, result in hypoprothrombinaemia, which may increase the risk of haemorrhagic events.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Women of childbearing potential have to use effective contraceptive measures during treatment. The use of carbimazole in pregnant women must be based on the individual benefit/risk assessment. If carbimazole is used during pregnancy, the lowest effective dose without additional administration of thyroid hormones should be administered. Close maternal, foetal and neonatal monitoring is warranted (see section 4.6).</p><p>&nbsp;</p><p><em>NeoMercazole</em><em><sup>&reg;</sup></em><em> contains lactose</em></p><p>NeoMercazole<sup>&reg;</sup><sup> </sup>contains lactose and sucrose. Patients with rare hereditary problems of galactose intolerance, the Lapp lactase deficiency or glucose-galactose malabsorption should not take this medicine.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="InteractionsOtherMedicines">4.5. Interactions with other medicinal products</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Little is known about interactions.</p><p>Interaction studies have not been performed in paediatric patients.</p><p>&nbsp;</p><p>Particular care is required in case of concurrent administration of medication capable of inducing agranulocytosis.</p><p>&nbsp;</p><p>It is difficult to distinguish between the effect of corrected hyperthyroidism and the specific effects of synthetic antithyroid drugs.</p><p>&nbsp;</p><p><em>Anticoagulants:</em></p><p>Since thyroid hormones can alter the amount of vitamin K-dependent clotting factors and thus the extent of inhibition by oral anticoagulants, careful control of anticoagulant dosage is required as hyperthyroid patients receiving treatment with carbimazole are rendered euthyroid; additional monitoring of PT/INR should be considered, especially before surgical procedures. Carbimazole administration can itself, rarely, result in hypoprothrombinaemia, which may increase the risk of haemorrhagic events.</p><p>&nbsp;</p><p><em>Theophylline:</em></p><p>The serum levels of theophylline can increase and toxicity may develop if hyperthyroidic patients are treated with antithyroid medications without reducing the theophylline dosage.</p><p><em>&nbsp;</em></p><p><em>Iodine deficiency:</em></p><p>Iodine deficiency will increase the response to carbimazole while an excess of iodine will attenuate it.</p><p>&nbsp;</p><p><em>Prednisolone:</em></p><p>Co-administration of prednisolone and carbimazole may result in increased clearance of prednisolone.</p><p>&nbsp;</p><p><em>Erythromycin:</em></p><p>Carbimazole may inhibit the metabolism of erythromycin, leading to reduced clearance of erythromycin.</p><p><em>&nbsp;</em></p><p><em>Digitalis:</em></p><p>Serum digitalis levels may be increased when hyperthyroid patients on a stable digitalis glycoside regimen become euthyroid; a reduced dosage of digitalis glycosides may be needed.</p><p>&nbsp;</p><p><em>Beta-blockers:</em></p><p>Hyperthyroidism may cause an increased clearance of beta-adrenergic blockers with a high extraction ratio. A dose reduction of beta blockers may be needed when a hyperthyroid patient becomes euthyroid.</p><p>&nbsp;</p><p><em>Interference with serological testing:</em></p><p>Hypoprothrombinemia and bleeding may be caused hence, prothrombin time should be monitored during therapy with the drug, especially before surgical procedures.</p><p><em>&nbsp;</em></p><p><em>Paediatric population:</em></p><p>Interaction studies have only been performed in adults.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="FertilityAndPregnantWarnings">4.6. Fertility, pregnancy and lactation</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Women of childbearing potential have to use effective contraceptive measures during treatment (see section 4.4).</p><p>&nbsp;</p><p><em>Pregnancy</em></p><p>&nbsp;</p><p>Hyperthyroidism in pregnant women should be adequately treated to prevent serious maternal and foetal complications. Carbimazole is able to cross the human placenta.</p><p>&nbsp;</p><p>Carbimazole and its active metabolite cross the placenta and may cause foetal hypothyroidism and thyroid hyperplasia. But, provided the mother&#39;s dose is within the standard range and her thyroid status is monitored; there is no evidence of neonatal thyroid abnormalities.</p><p>&nbsp;</p><p>Based on human experience from epidemiological studies and spontaneous reporting, carbimazole is suspected to cause congenital malformations when administered during pregnancy, particularly in the first trimester of pregnancy and at high doses.</p><p>&nbsp;</p><p>Reported malformations include aplasia cutis congenita, craniofacial malformations (choanal atresia; facial dysmorphism), exomphalos, oesophageal atresia, omphalo-mesenteric duct anomaly, and ventricular septal defect.</p><p>&nbsp;</p><p>Carbimazole must only be administered during pregnancy after a strict individual benefit/risk assessment and only at the lowest effective dose without additional administration of thyroid hormones. If carbimazole is used during pregnancy, close maternal, foetal and neonatal monitoring is recommended (see section 4.4).</p><p>&nbsp;</p><p>Studies have shown that the incidence of congenital malformations is greater in the children of mothers whose hyperthyroidism has remained untreated than in those who have been treated with carbimazole.</p><p>&nbsp;</p><p>However, cases of congenital malformations have been observed following the use of</p><p>carbimazole or its active metabolite methimazole during pregnancy.</p><p>&nbsp;</p><p>Transient thyroid function abnormalities have been reported in newborns born to mothers treated with carbimazole during pregnancy.</p><p>&nbsp;</p><p>In humans, the foetal thyroid gland begins to trap iodine 10-12 weeks after conception.</p><p>&nbsp;</p><p>However, cases of congenital malformations such as circumscribed aplasia of the scalp, choanal atresia, oesophageal atresia have been observed following the use of carbimazole or its active metabolite methimazole during pregnancy.</p><p>&nbsp;</p><p>A causal relationship of these malformations, especially choanal atresia and aplasia cutis congenita (congenital scalp defects), to transplacental exposure to carbimazole and methimazole cannot be excluded.</p><p>&nbsp;</p><p>Therefore, the use of NeoMercazole<sup>&reg;</sup> in non-pregnant women of childbearing potential should be based on individual risk/benefit assessment (see section 4.4).</p><p>&nbsp;</p><p>Cases of renal, skull, cardiovascular congenital defects, exomphalos, gastrointestinal malformation, umbilical malformation and duodenal atresia have also been reported. Therefore, carbimazole should be used in pregnancy only when propylthiouracil is not suitable. If NeoMercazole<sup>&reg;</sup> is used in pregnancy the dose of NeoMercazole<sup>&reg;</sup> must be regulated by the patient&#39;s clinical condition. The lowest dose possible should be used, and this can often be discontinued three to four weeks before term, in order to reduce</p><p>the risk of neonatal complications.</p><p>&nbsp;</p><p>If a pregnant woman takes NeoMercazole<sup>&reg;</sup> or a female patient becomes pregnant during treatment, they must be informed of the possible risks for the unborn child. If NeoMercazole<sup>&reg;</sup> is used in pregnancy, the dose must be regulated by the patient&#39;s clinical condition. The lowest dose possible should be used, and this can often be discontinued three or four weeks before term, in order to reduce the risk of neonatal complications.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The posologies will need to be adjusted to obtain normal thyroid function or mild maternal hyperthyroidism in order to limit the risk of foetal hypothyroidism. Maternal supplementation with L-thyroxine might prove ineffective for the foetus because it barely crosses the placenta.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A prenatal exam (ultrasound) should be considered in order to detect some of the above-cited malformations and to monitor the foetal thyroid gland.</p><p>&middot;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; A neonatal thyroid function test should be performed.</p><p>&nbsp;</p><p>The blocking-replacement regimen should not be used during pregnancy since very little thyroxine crosses the placenta in the last trimester.</p><p>&nbsp;</p><p><em>Breast-feeding</em></p><p>Carbimazole is excreted in milk, due to the risk of neonatal hypothyroidism, breast-feeding is contraindicated and if treatment is continued during lactation the patient should not continue to breast-feed her baby. In the use of high doses there is a risk of hypothyroidism, as well as agranulocytosis in the infant.</p><p>&nbsp;</p><p>If appropriate, switching to treatment with propylthiouracil should be considered, since the latter passes into breast milk about ten times less freely than does thiamazole.</p><p>&nbsp;</p><p><em>Fertility</em></p><p>No special recommendations.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="EffectsAbilityDriveMachines">4.7. Effects on ability to drive and use machines</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No studies on the effects on the ability to drive and use machines have been performed.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="UndesirableEffects">4.8. Undesirable effects</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Adverse reactions generally usually occur in the first eight weeks of treatment. The most frequently occurring reactions are nausea, headache, arthralgia (especially in the joint of the thumb), mild gastrointestinal disorder, rash, pruritus and urticaria. These reactions are generally self-limiting and do not require withdrawal of the drug.</p><p>Unless otherwise stated, the frequency of undesirable effects is unknown.</p><p><strong><u>&nbsp;</u></strong></p><p>Paediatric population</p><p>Frequency, type and severity of adverse reactions in children appear to be comparable</p><p>with those in adults.</p><p><strong><u>&nbsp;</u></strong></p><p><em>Infections and infestations</em></p><p>Furuncle, sialoadenitis</p><p><strong><u>&nbsp;</u></strong></p><p><em>Blood and lymphatic system disorders</em></p><p>Bone marrow failure including neutropenia, eosinophilia, leukopenia and agranulocytosis has been reported. Fatalities with carbimazole-induced agranulocytosis have been reported (see section 4.4).</p><p>&nbsp;</p><p>Rare cases of hypoprothrombinaemia, pancytopenia/aplastic anaemia and isolated thrombocytopenia have also been reported. Additionally, lymphadenopathy and very rare cases of haemolytic anaemia have been reported (see section 4.4).</p><p>&nbsp;</p><p>The occasional and usually sudden onset (in 0.5 to 1% of cases) of bone-marrow aplasia.</p><p>&nbsp;</p><p>Patients should always be warned about the onset of oropharyngeal pain, contusion or haemorrhage, mouth ulceration, pyrexia, discomfort and malaise and should be instructed to stop the drug and to seek medical advice immediately. In such patients, white blood cell counts should be performed immediately particularly where there is any clinical evidence of infection.</p><p>&nbsp;</p><p>Generalised lymphadenopathy.</p><p>&nbsp;</p><p><em>Immune system disorders</em></p><p>Angioedema and multi-system hypersensitivity reactions such as cutaneous vasculitis, hepatic, pulmonary and renal effects may occur.</p><p>&nbsp;</p><p><em>Endocrine disorders</em></p><p>Insulin autoimmune syndrome (with pronounced decline in blood glucose level) may develop and could even lead to shock hypoglycaemic.</p><p>Hypothyroidism and worsening of goiter.</p><p><em>&nbsp;</em></p><p>An increase in volume of the goiter may occur, in a manner similar to hypothyroidism following overdosage, worsening of goiter.</p><p>&nbsp;</p><p><em>Nervous system disorders</em></p><p>Nervous system disorder, headache, neuritis, polyneuropathy, ageusia (rare cases), dizziness and paraesthesia.</p><p>&nbsp;</p><p><em>Eye disorders</em></p><p>Exophthalmos.</p><p>&nbsp;</p><p><em>Vascular disorders</em></p><p>Haemorrhage.</p><p>&nbsp;</p><p><em>Gastrointestinal disorders</em></p><p>Stomatitis, nausea, moderate gastrointestinal disorder, abdominal pain and abdominal pain upper, Loss of sense of taste has been observed, acute salivary gland swelling.</p><p>&nbsp;</p><p><em>Hepatobiliary disorders</em></p><p>Liver disorders, including, hepatitis, hepatitis cholestatic (rare cases), jaundice cholestatic, hepatic necrosis (rare cases) and most commonly jaundice have been reported; in these cases NeoMercazole<sup>&reg;</sup> tablets should be withdrawn. Jaundice may persist for several weeks after discontinuation of the treatment</p><p>&nbsp;</p><p><em>Skin and subcutaneous tissue disorders</em></p><p>Rash, pruritus, urticaria have been reported commonly, alopecia has been occasionally reported. Pigmentation disorder, dermatitis and erythema may occur.</p><p>&nbsp;</p><p>Severe dermatitis allergic reactions have been reported in both adult and paediatric patients, including Stevens-Johnson syndrome (very rare including isolated reports: severe forms, including generalised dermatitis, have only been described in isolated cases).</p><p>&nbsp;</p><p><em>Musculoskeletal and connective tissue disorders</em></p><p>Arthralgia (especially in the joint of the thumb), isolated cases of myopathy and muscle disease have been reported. Patients experiencing myalgia after the intake of NeoMercazole<sup>&reg;</sup> tablets should have their creatine phosphokinase levels monitored.</p><p>&nbsp;</p><p><em>General disorders and administration site conditions</em></p><p>Pyrexia, malaise and fatigue.</p><p>&nbsp;</p><p><em>Investigations</em></p><p>Liver function test abnormal.</p><p>&nbsp;</p><p><em>Injury, poisoning and procedural complications</em></p><p>Contusion.</p><p>&nbsp;</p><p><em>Gastro-intestinal system disorders </em></p><p>Not known: Acute pancreatitis</p><p><strong>&nbsp;</strong></p><p><strong>-To reports any side effect(s): </strong></p><p>&nbsp;</p><p>o&nbsp;&nbsp; The National Pharmacovigilance and Drug Safety Centre (NPC)</p><p>o&nbsp;&nbsp; Fax: +966-11-205-7662</p><p>o&nbsp;&nbsp; Call NPC at +966-11-2038222, Exts: 2317-2356-2340.</p><p>o&nbsp;&nbsp; SFDA Call Center: 19999</p><p>o&nbsp;&nbsp; E-mail: npc.drug@sfda.gov.sa</p><p>o&nbsp;&nbsp; ebsite: http://ade.sfda.gov.sa</p><p>&nbsp;</p><p>&bull; <strong>Other GCC States:</strong> Please contact the relevant competent authority.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Overdoes">4.9. Overdoes</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Symptoms</em></p><p>Normally no symptoms are likely from a single large dose. Onset of hypothyroidism with elevated TSH and increased goiter volume, as well as increasing the risk of agranulocytosis may occur.</p><p>&nbsp;</p><p><em>Treatment</em></p><p>No specific treatment is indicated. In case of manifest overdosing, the treatment must be discontinued and, if necessary, the symptoms treated.</p><p>&nbsp;</p><p>Forced diuresis, haemodialysis, peritoneal dialysis and haemoperfusion have not been found effective in the treatment of overdoses of carbimazole.</p>
            </div>
        </div>
    </div>

    <div class="col-xs-12">
        <label style="float: left">5. PHARMACOLOGICAL PROPERTIES</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PharmacodynamicProperties">5.1. Pharmacodynamic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>5.1&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Pharmacodynamic properties</p><p>Pharmacotherapeutic group: Sulfur-containing imidazole derivatives (antithyroid preparation)</p><p>ATC Code: H03BB01</p><p>&nbsp;</p><p><em>Mechanism of action:</em></p><p>Carbimazole, a thionamide, is a pro-drug which undergoes rapid and virtually complete metabolism to the active metabolite, thiamazole, also known as methimazole, which has a prolonged antithyroid effect. The method of action is believed to be inhibition of the organification of iodide and the coupling of iodothyronine residues which in turn suppress the synthesis of thyroid hormones.</p><p>&nbsp;</p><p>Since carbimazole inhibits the action of thyroid peroxidase, it prevents the oxidation of iodides and their uptake by the tyrosyl radicals of thyroglobulin as well as the coupling of iodotyrosines with iodothyronines (T<sub>3</sub> and T<sub>4</sub>).</p><p>&nbsp;</p><p>Alongside these two effects, both typical of all synthetic antithyroid agents, carbimazole also has another particular property: it blocks the enzyme dehalogenase, which enables recovery of any organic iodine that has not been distributed. Intrathyroid iodine is thus gradually eliminated, leading to iodine avidity in the thyroid gland. This means that it is always possible to replace radioactive iodine treatment with NeoMercazole<sup>&reg;</sup>.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
                <label style="float: left" for="PharmacokineticProperties">5.2. Pharmacokinetic Properties</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p><em>Absorption</em></p><p>Between 90 and 100% of orally administered carbimazole is rapidly absorbed in the intestines within 15-30 minutes. Only its active metabolite, methimazole, can be identified in the blood. The mean peak plasma concentration of thiamazole is reported to occur one hour after a single dose of thiamazole.</p><p>&nbsp;</p><p>After oral ingestion, peak plasma concentrations of thiamazole, the active moiety, occur at 1 to 2 hours</p><p><strong><u>&nbsp;</u></strong></p><p><em>Distribution</em></p><p>The total volume of distribution of thiamazole is 0.5L/kg and is moderately (about 40%) bound to plasma proteins. Thiamazole is concentrated in the thyroid gland. This intra-thyroidal concentration of thiamazole has the effect of prolonging the activity of carbimazole. When low doses are administered the ratio of the thyroid to plasma is about 100, which drops as the dose is raised and as saturation of the transport system increases. However, thiamazole has a shorter half-life in hyperthyroid patients than in normal controls and so more frequent initial doses are required while the hyperthyroidism is active.</p><p><u>&nbsp;</u></p><p>Carbimazole and thiamazole cross the placenta and appear in breast milk. The plasma milk ratio for thiamazole approaches unity.</p><p><u>&nbsp;</u></p><p><em>Biotransformation</em></p><p>Thiamazole is moderately (about 40%) bound to plasma proteins. Carbimazole has a half-life of 5.3 to 5.4 hours. It is possible that the plasma half-life may also be prolonged by renal or hepatic disease. See section 4.2. Thiamazole crosses the placenta and appears in breast milk. The plasma: milk ratio approaches unity.</p><p>Carbimazole is transformed into its active metabolite thiamazole in the blood by hydrolysis and enzymatic decarboxylation. Only its active metabolite thiamazole (methimazole) can be detected in the blood, so the pharmacokinetic data therefore refer to this metabolite.</p><p><strong><u>&nbsp;</u></strong></p><p><em>Elimination</em></p><p>The blood half-life ranges from 4-12 hours depending on the person.</p><p>&nbsp;</p><p>Over 90% of orally administered carbimazole is excreted in the urine as thiamazole or its metabolites. The remainder appears in faeces. Approximately 7% of methimazole is excreted unchanged. There is 10% enterohepatic circulation.</p><p>&nbsp;</p><p>The dwell time of thiamazole in the thyroid amounts to about 20 hours, which corresponds to the duration of the effect of a single dose.</p><p><em>&nbsp;</em></p><ol><li><em>Characteristics in patients</em></li></ol><p>The plasma half-life is longer in patients with disorders of the liver or kidney functions (see section 4.3).</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PreclinicalSafetyData">5.3 Preclinical Safety Data</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>There are no preclinical data of relevance to the prescriber which are additional to that already included in other sections of the Summary of Product Characteristics.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <label style="float: left">6. PHARMACEUTICAL PARTICULARS</label>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ExcipientsList">6.1 Excipients List</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Sucrose, lactose, acacia, talc, maize starch, magnesium stearate, gelatine and red iron oxide (E172)</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="Incompatibilities">6.2. Incompatibilities</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>None known</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ShelfLife">6.3. Shelf Life</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                3 years
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="PrecautionsStorageConditions">6.4. Special precautions for storage</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>Do not store above 25&deg;C.</p><p>Store in the original container away from heat.</p><p>Do not use after the expiry date which is printed on the carton after EXP. The expiry date refers to the last day of that month.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="ContainerContents">6.5. Nature and contents of container</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>NeoMercazole&reg; 5mg tablets are available in HDPE bottles with a polypropylene tamper-evident screw cap with integrated desiccant. Each bottle contains 100 Tablets.</p>
            </div>
        </div>
    </div>
    <div class="col-xs-11 col-offset">
        <div class="clearfix">
            <label style="float: left" for="SpecialPrecautionsDisposal">6.6. Special precautions for disposal and other handling</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                <p>No special requirements<strong>.</strong></p>
            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="AuthorizationMarketingHolder">7. MARKETING AUTHORISATION HOLDER</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                Amdipharm Limited,
Temple Chambers, 3 Burlington Road, Dublin 4, Ireland.
Tel No: + 353 (0) 1 697 1640
Fax No: + 353 (0) 1 697 1641
Email: enquiries@advanzpharma.com 

            </div>
        </div>
    </div>
    <div class="col-xs-12">
        <div class="clearfix">
            <label style="float: left" for="RevisionDateText">8. DATE OF REVISION OF THE TEXT</label>
        </div>
        <div class="form-group">
            <br />
            <div class="ltr">
                05/2020
            </div>
        </div>
    </div>
</div>

            }    </div>
    <div id="f-div" class="box-data">
        
<div class="row clearfix rtl">
    <div class="container-fluid">
        <!-- Basic Example -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>صورة المنتج على الرف</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic" data-slide-to="0" class="active"></li>
                        <li data-target="#carousel-example-generic" data-slide-to="1" class=""></li>
                        <li data-target="#carousel-example-generic" data-slide-to="2" class=""></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                            
                                <img src="/images/nodrugimags.png">
                        </div>

                    </div>

                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# Basic Example -->
        <!-- With Captions -->
        <div class="col-lg-6 col-md-6 col-sm-6 col-xs-6">
            <div class="header">
                <h2>الصورة الاساسية</h2>
            </div>
            <div class="body">
                <div id="carousel-example-generic_2" class="carousel slide" data-ride="carousel">
                    <!-- Indicators -->
                    <ol class="carousel-indicators">
                        <li data-target="#carousel-example-generic_2" data-slide-to="0" class=""></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="1" class="active"></li>
                        <li data-target="#carousel-example-generic_2" data-slide-to="2"></li>
                    </ol>
                    <!-- Wrapper for slides -->
                    <div class="carousel-inner" role="listbox">
                        <div class="item active">
                                <img src="/images/nodrugimags.png">
                        </div>
                    </div>
                    <!-- Controls -->
                    <a class="left carousel-control" href="#carousel-example-generic_2" role="button" data-slide="prev">
                        <span class="glyphicon glyphicon-chevron-right" aria-hidden="true"></span>
                        <span class="sr-only">Previous</span>
                    </a>
                    <a class="right carousel-control" href="#carousel-example-generic_2" role="button" data-slide="next">
                        <span class="glyphicon glyphicon-chevron-left" aria-hidden="true"></span>
                        <span class="sr-only">Next</span>
                    </a>
                </div>
            </div>
        </div>
        <!-- #END# With Captions -->
    </div>
</div>


    </div>

    <!-- #END# Tabs With Custom Animations -->
</div>
        <a style="background-image: url('../images/banner.png');"
           class="scroll-top">
            <img style="margin: 15px;" src="/images/icons/up-arrow2.png" width="35">
        </a>

        <div class="footer navbar-fixed-bottom">
            <small style="color: white; margin-left: 30px;">All Rights Reserved - SFDA &copy; 2020</small>
            <br class="visible-xs visible-sm"><br class="visible-xs visible-sm">

        </div>
    </section>


    <script src="/lib/json2/json2.js?v=w3DjWhUtDqy3bSJKv285C-2kagUtW9F64T9z3xRah8g"></script>
    <script src="/lib/jquery/dist/jquery.js?v=w4hyv6-vmv08RC2hK00wXgxDziKII9paMAbU_M-5dgY"></script>
    <script src="/lib/bootstrap/dist/js/bootstrap.js?v=T574NvJTWc-Pan8hAmnXXc0eZFiqKRp7xQ3sz5QiFOk"></script>
    <script src="/lib/moment/min/moment-with-locales.js?v=5f0RFtuChrGi6osDzegxXWf5yOkmx45i7J9fM1p6P5w"></script>
    <script src="/lib/jquery-validation/dist/jquery.validate.js?v=ZDzsHzuLAtqQVxXwbgRtfAPXQ7UAoJRXBAUDvc9G9CI"></script>
    <script src="/lib/blockUI/jquery.blockUI.js?v=KKcUNqwNyTLaXzvuMyFk6JisiQq6Hk7ZtrciXnEf3Z0"></script>
    <script src="/lib/toastr/toastr.js?v=s1ewxfN8Vn23TAVRLUk8XiQUAw6uWhhuPO9dmtYzUiA"></script>
    <script src="/lib/sweetalert/dist/sweetalert.min.js?v=aPktydUv1rN3mouQeXoKi3ioFTIQlULuqYeoTAA2ihY"></script>
    <script src="/lib/spin.js/spin.js?v=b1plKpQIB-XuGyjWec42MhmhpPzEPzFI3OC8Ia0XIoc"></script>
    <script src="/lib/spin.js/jquery.spin.js?v=i7H7HL08ldqUANgfQInE7LlU2uWUdQMCJ-Q7-_zLutY"></script>
    <script src="/lib/bootstrap-select/dist/js/bootstrap-select.js?v=tXulJKckrq2j2wo8a9hvmXLDEQwhGviPTIYmEzy1dNI"></script>
    <script src="/lib/jquery-slimscroll/jquery.slimscroll.js?v=ESVSX4dkOxamaRoYfcqPM2FfErhgfxS60fp1Fa8ou1w"></script>
    <script src="/lib/Waves/dist/waves.js?v=ZOMv1vwqpT_ezNZGhvr9jJTr_jqu3lYHB7vmpxD7HmA"></script>
    <script src="/lib/push.js/push.js?v=w347yqiscLjM_TxUKpqeUA1LDR3w5vshQpxpTsgkLhE"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/abp.js?v=EjNSmvtPSqCVK_xG_aTvOp8hmVM_7vwyd3hg45CAMGk"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.jquery.js?v=XEXcdRYb4eN3XoQCbnM-BSR6UifHRLsXYDIVFZ7Oc6Q"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.toastr.js?v=h3viOCmHM1K7HnYUuJPDvLchk2Ge8CoKvl6ZJfICgII"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.blockUI.js?v=vMuHbqHh635SKL2RG2qsGGCDyHg1yFeGqhPKpS34g4k"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.spin.js?v=djoKib6ssm5DDzbXLe5pD7ayfFg3siaoEk-BFYzQlvI"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.sweet-alert.js?v=fPp3O_ILaqD0UHiR721w1i4iBtxo3NH7yfldI5dg0_I"></script>
    <script src="/js/admin.js?v=nakObLuf3yPs2VlWrIris5w-48c36X3YIRrxIis7IKQ"></script>
    <script src="/js/main.js?v=x_HDlXByl0okIi4i04d4Q_fNr85GPQi1W8gjs82s-n8"></script>
    <script src="/view-resources/Views/Shared/_Layout.js?v=36YkLzPJaGejZMB10f2T6f1rMVIzDKq96kjfcnxcLVg"></script>


        <script src="/lib/jquery-validation/src/localization/messages_ar.js?v=6kzy-p-PtvkHPWdHWyjMOIfwhBFlUYYv9jnF7zJnpUI"></script>

    <!-- Dynamic scripts of ABP system (They are created on runtime and can not be bundled) -->
    <script src="/AbpServiceProxies/GetAll?v=638865394571695575" type="text/javascript"></script>
    <script src="/AbpScripts/GetScripts?v=638865394571695575" type="text/javascript"></script>
    <script src="/lib/signalr-client/signalr.min.js?v=1yGr-J4NjYMQVt6LP6vocjHIWhO-BFQLfdCs8x1Mv-U"></script>
    <script src="/lib/abp-web-resources/Abp/Framework/scripts/libs/abp.signalr-client.js?v=jTdZBAadu6DXq0iDTFX6vsn4q6bFhKm3XfN8Jz6dSmg"></script>
    
    <!-- View specific scripts -->
    
    <script src="/view-resources/Views/Home/Index.js?v=mAIakROmG_IlahImCtfrMSdaLPTG5Uoh6Z0hM1g3cxw"></script>
    <script src="/view-resources/Views/Home/Result.js?v=0pEgOuTQc8ZyJaaOpJCG7ytkKSCkzEMYCHEJfKDWu4k"></script>
    <script src="/view-resources/Views/Home/DrugsSearch.js?v=04aRniTG_ClH5tABzf7EDwQgWVpkDNpjeJUDSGvOK_Y"></script>

</body>
</html>